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ABSTRACT
One third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that 
causes TB. During an infection, bacteria often survive host immune system attacks, which include 
oxidative stress conditions for bacteria growing inside macrophages. This makes treatment difficult 
and time-consuming. We hypothesize bacteria can adapt to environmental conditions by changing 
their mRNA maturation and degradation profiles. Using a model system, Mycobacteruim 
smegmatis, we focus on how mRNA expression is affected by oxidative stress. After construction 
and sequencing of RNA expression libraries, preliminary analysis showed that after three hours of 
H2O2 exposure most upregulated genes were related to DNA repair, while downregulated genes 
included  transport proteins. After six  hours of exposure, upregulated genes were similar to three 
hours and downregulated genes included tRNAs. 5' end mapping libraries were also constructed to 
access differential cleavage site abundance under oxidative stress conditions. We also investigated 
the roles RNase J may have in stress response and mRNA processing in Mycobacteria. RNase J and 
RNase E are thought to be the major RNases in bacteria. While most bacteria only have one of 
them, mycobacteria encode both in their genome, with RNase J being non-essential. We constructed 
a set of 4 strains (WT, RNase J  overexpression, RNase J deletion,  and complemented RNase J 
deletion) and tested their drug resistance and stress tolerance. Results suggests that RNase J deletion 
and overexpression alter drug sensitivity. Stress tolerance assays showed that WT is more tolerant to 
oxidative stress, followed by RNase J deletion strain and overexpression and complemented RNase 
J deletion strains, with the last two showing no growth when cultured with H2O2. Analysis of the 
expression profile of these strains was performed to help understand if gene expression differences 
are responsible for the phenotypes observed. For the complemented RNase J deletion, one operon 
had almost all its genes upregulated. This operon encodes a hydrogenase (Hyd3), suggesting that 
redox balance in the strain is perturbed.
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1. INTRODUCTION TO  TUBERCULOSIS  AS  A  GLOBAL  PUBLIC  HEALTH 
PROBLEM
Mycobacterium tuberculosis is  the causative agent of tuberculosis  (TB),  which normally 
affects  the  lungs  and  can  be  fatal  without  proper  treatment.  According  to  the  World  Health 
Organization (WHO), latent TB is estimated to infect 2 to 3 billion people worldwide while around 
5% to 15% of this group will develop active TB disease during life. WHO recommends that patients 
with  drug-susceptible  TB are  treated  with  a  combination  of  isoniazid  (INH),  rifampicin  (RIF), 
ethambuthol and pyrazinamide for 2 months followed by a treatment with only INH and RIF for 4 
months (WHO, 2015). For being quite a long treatment, some patients do not complete the full 6 
months of treatment, which facilitates the development of drug resistant TB.  Multidrug-resistant 
strains (MDR) are already a problem worldwide (Figure 1). These strains are resistant to both INH 
and RIF and the recomended treatment includes 20 months of more expensive and toxic drugs 
(WHO, 2015).
Figure 1: Global trend of multi-drug resistant (MDR-TB) cases and additional RIF-resistant TB cases 
detected (red) from 2009 to 2014 compared to number of TB patients treated with MDR-TB specific drug from 
2009 to 2014 (blue). Modified from WHO, 2015.
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Figure 2: Estimated new global TB cases (all forms) per 100,000 population in 2014. Retrieved from 
WHO, 2015.
Figure 2 shows that the majority of new cases are concentrated in Africa and Asia. When we 
look at the high-burden countries, places where the incidence, prevalence and mortality of TB are 
high (WHO, 2015), as shown in the following table, are mainly in developing countries.
Table 1: 22 high-burden countries according to WHO, 2015.
22 countries with high TB burden
Afghanistan Ethiopia Nigeria Uganda
Bangladesh India Pakistan United Republic of 
Tanzania
Brazil Indonesia Philippines Viet Nam
Cambodia Kenya Russian Federation Zimbabwe
China Mozambique South Africa
Democratic Republic 
of Congo
Myanmar Thailand
The majority of these countries do not have sufficient resources to offer people proper health 
care, and that is part of the reason why the number of TB cases remains alarming. It is reported that 
the 22 high-burden countries represent 80% of the TB cases worldwide (WHO, 2015).
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In 2014, 1.5 million deaths were attributed to TB around the globe (WHO, 2015). 
Considering that this disease has an extremely high cure rate when promptly  diagnosed and 
correctly treated, the number of deaths is surprising (WHO, 2015). As stated before, the long 
treatments used for TB can be a problem for most people that might stop taking the medicine once 
they start to feel better even if the 6 months of treatment are not over. It is therefore important to 
study the biology of TB in order to find a better and faster way to fight this disease.
Starting in 1921, the BCG vaccine was administrated in humans to protect against the effects 
of TB. The vaccine consists in an attenuated strain of Mycobacterium bovis developed at the Pasteur 
Institute in France (CDC, 1996). Between 1945 and 1975, several studies were conducted to address 
BCG vaccine efficacy with results ranging between zero to 80% (CDC, 1996). In young children 
BCG is  considered  effective  against  tuberculous  meningitis  and miliary tuberculosis,  while  the 
protection effectiveness for pulmonary TB varies from 2 to 80% (CDC, 1996).
BCG vaccination can commonly lead to false-positive results in the tuberculin skin test. The 
test is not able to differentiate between those currently infected with TB and who have an immune 
response to the BCG and react to the tuberculin  (CDC, 1996). Is reported that people previously 
vaccinated with BCG showed reactivity between 0 to 19 mm when tested, and the recommendations 
from CDC are that TB diagnosis can be made if for a BGC-vaccinated person the induration on the 
test is ≥ 10 mm (CDC, 1996).
Taken  together  this  information  led  us  to  conclude  that  BCG  vaccination  does  not 
necessarily protect people from getting TB infection, with its efficacy being uncertain, and testing 
can lead to false-positives from the BCG vaccine (CDC, 1996). For these reasons some countries 
where the disease is rare, like the U.S., limit the vaccination to only groups at risk (CDC, 1996).
These findings about BCG efficacy and possible problems help corroborate that,  besides 
finding a better and faster way to fight this disease, we also need a better strategy to prevent new 
cases of TB.
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1.1. CURRENT TREATMENTS FOR TUBERCULOSIS
As stated in section 1, it is recommended that patients with drug-susceptible TB are treated 
with  a  combination  of  isoniazid  (INH),  rifampicin  (RIF),  ethambuthol  and pyrazinamide  for  2 
months followed by a treatment with only INH and RIF for 4 months (WHO, 2015).
Isoniazid is a prodrug that, once inside the mycobacterial cell, is converted to the active drug 
by the catalase-peroxidase KatG (Timmins and Deretic, 2006). This conversion generates reactive 
species  that  inhibit  mycolic  acid  synthesis  (Timmins  and  Deretic,  2006).  Rifampicin  stops 
transcription  initiation  in  bacteria  by targeting  the  β subunit of  RNA polymerase  (gene  rpoB) 
(Agrawal et al, 2015).
Figure  3:  Drugs  used  for  treatment  of  drug-susceptible  TB.  Reproduced  from 
http://www.sigmaaldrich.com/united-states.html
Ethambutol is capable of arresting the multiplication of mycobacterial cells making cells 
non-viable after several hours of application (Forbes et al., 1962). Its effect is due to interference of 
ethambutol in the synthesis of key metabolites for cell multiplication, that will then impair cell 
metabolism and eventually make then lose viability (Forbes  et al.,  1962). The drug inhibits the 
transference  of  mycolic  acids  to  the  cell  wall  of  M.  smegmatis (Takayama  et  al.,  1979) 
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Pyrazinamide,  on  the  other  hand,  is  converted  to  pyrazinoic  acid  by  PZase  once  inside  the 
mycobacterial  cell  and  inhibits  membrane  transport  function  in  M.  tuberculosis by  disrupting 
membrane  energetics  (Zhang  et  al.,  2003).  The  drug  will  target  more  efficiently  the  old  non-
replicating bacteria as their membrane is fragile and normally present a lower membrane potential 
with less active metabolism when compared with young replicating bacteria (Zhang et al., 2003).
These four drugs (figure 3) are the first line of treatment against  M. tuberculosis and are 
effective in most of the cases when administrated to eliminate drug-susceptible TB. In the case of a 
patient with drug-resistant TB, second line drugs, like fluoroquinolones, can be used.
Fluoroquinolones  are  a  class  of  antibiotics  that  interacts  with  DNA  gyrase  and 
topoisomerase IV (Hooper, 2000). The drug forms a complex with those two enzymes and prevents 
DNA replication in bacteria (Hooper, 2000).
1.2.  ROLE OF POST-TRANSCRIPTIONAL REGULATION IN MYCOBACTERIAL 
STRESS RESPONSE
In order to address these issues it is necessary to understand how mycobacteria can adapt to 
hostile environments and thrive there, like for example the human body. When infecting a host 
Mycobacterium tuberculosis (Mtb) has to find ways to avoid the immune response and, when it is 
not able to avoid it, resist the host "attacks". When infecting a host, Mtb resides in the macrophages 
(Pieters, 2008). The metabolism of a macrophage in the lung liberates reactive oxygen species 
(ROS) that affect the bacteria growing inside these cells (Dussurget et al, 1998).
This process will only happen if Mtb becomes phagocytosed by an activated macrophage 
where the phagosome and the lysosome fuse in an attempt to kill the bacteria (Pieters, 2008). In the 
case that the bacteria get phagocytosed by a non-activated macrophage, it can prevent the fusion of 
the phagosome with the lysosome by a cholesterol mediated mechanism, and this allows Mtb to 
avoid facing high concentrations of ROS that can damage the cells (Pieters, 2008). Tolerance to 
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ROS and oxidative stress seems to play a role in Mtb infection and survival within a host but the 
mechanisms remain to be fully elucidated. ROS and oxidative stress effects on mycobacteria will be 
covered more in depth in section 1.3.
Transcript degradation is known to help bacteria to adapt to different environments by 
performing RNA cleavage and changing their expression profile (Arraiano et al, 2010). The 
enzymes that play a major role in RNA cleavage are the RNases (ribonucleases). RNases are known 
to function as a clean up mechanism for the cell, as they take part in degradation of transcripts and 
protect the cell from producing aberrant proteins from defective RNAs (Arraiano et al, 2010).
The ability of a particular transcript to evade the action of RNases can dictate its stability. 
Most mRNA can escape from the RNases by using secondary structures to "hide" the cleavage  sites 
or, in the case of a highly translated mRNA, the ribosomes will help to protect the transcript 
(Arraiano et al, 2010).
RNA processing can also make a transcript more stable in response to environmental 
conditions, and this will also help to determine the amount of that specific protein in the cell 
(Rochat et al, 2013). Some RNAs, for  example tRNA and rRNA, are only completely functional 
following transcript cleavages during maturation (Arraiano et al, 2010).
Once cleaved by an RNase, a can have the following possible fates: the entire transcript can 
be  (1) destabilized and then degraded, (2) selectively destabilized or stabilized, where one fragment 
may go under degradation and the other will get more stable and presumably more protein will be 
translated, and (3) entirely stabilized (Figure 4).
It is also worth noting that the 5' end of the primary transcript contains a triphosphate while 
the 5' end after the cleavage site contains a monophosphate, and this is a key feature to differentiate 
between the 5' end origin and identify mRNA cleavage sites that may lead to transcript stabilization 
genome-wide (Güell et al, 2011). 
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Figure 4: Possible fates a transcript may have after cleavage by an RNase.
Since RNases play a critical role in mRNA fate in the bacterial cell, and mRNA profiles can 
be changed due to environmental conditions, understanding how and in which conditions RNases 
work can help us to understand how Mtb adapt to the stress conditions it faces when infecting a 
host.
Table 2: Occurrence of RNases in different bacteria. Modified from Traverniti et al, 2011.
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Table 2 shows the occurrence of RNases in various  bacteria. E. coli has RNase E but not 
RNase J, while B. subtilis has RNase J but not RNase E. Mycobacteria, on the other hand, have both 
RNase E and RNase J, and this combination was not found in any other bacteria analyzed 
(Traverniti et al, 2011). RNase E is known to be an essential gene in mycobacteria, while RNase J is 
non-essential (Traverniti et al, 2011). The fact that it  is a non-essential gene makes it possible to 
knock out RNase J more easily, and this knock out  strain in M. smegmatis is known to have no 
growth defect (Traverniti et al, 2011). RNase J is also known to have exo and endoribonucleotic 
activity, which is unlike any other of the RNases presented on table 2, and also plays a role in 
ribosomal RNA maturation and stability (Traverniti et al, 2011). For all these reasons we decided to 
look at the roles that RNase J may have in mRNA cleavage and adaptation to stress. More 
information about RNase J can be found in section 1.3.
To perform the work described in this thesis, Mycobacterium smegmatis was used as a 
model system for Mycobacterium tuberculosis. M. smegmatis is a non-pathogenic fast growing 
mycobacteria which, as can be seen in table 2, has the same RNases as Mtb (Traverniti et al, 2011). 
The fact they have similar RNases suggests that the RNA degradation and maturation patterns are 
the same in M. smegmatis and Mtb (Traverniti et al, 2011). Genetic manipulation can be done in M. 
smegmatis relatively easily using molecular biology tools (Altaf et al, 2010), which corroborates its 
use as a model system for Mtb.
1.3. OXIDATIVE STRESS IN MYCOBACTERIA
ROS (reactive oxygen species) are known to be involved in several biological processes, for 
example: mutation, degenerative diseases, aging, development, inflammation and cell signaling 
(Kohen and Nyska, 2002).
The catalytic process of some enzymes and the dismutation of superoxide can produce H2O2, 
which can damage the cell in concentrations as low as 10 μM and can diffuse across biological 
8
membranes (Kohen and Nyska, 2002). The damage caused by the presence of H2O2 includes 
degradation and/or inactivation of proteins, release of iron inside the cell, and oxidation of 
structures such as DNA and lipids (Kohen and Nyska, 2002). Figure 4 shows the reaction of iron 
with hydrogen peroxide (H2O2). Iron ions are the most likely to take part in the Fenton reaction 
because of the high amount present in the cells when compared with other metals (Kohen and 
Nyska, 2002). When those ions are present on the surface of proteins and DNA it can facilitate the 
H2O2 related damage to those structures due to the proximity between the molecule and the radicals 
generated  after the H2O2 decomposition (Kohen and Nyska, 2002).
Figure 5: Fenton reaction between iron and hydrogen peroxide. This reaction may occur with any 
transition metal that contains un-paired electrons. Reproduced from (Kohen and Nyska, 2002).
Most ROS have short half-lives since they react with other molecules very rapidly; OH• is an 
example of such a ROS (Kohen and Nyska, 2002). H2O2 on the other hand is somewhat more stable 
and can reach other sites in the cells far from where it was originally produced (Kohen and Nyska, 
2002).
If an  organism is growing aerobically it will generate ROS due to the oxidation of redox 
enzymes (Broden et al, 2016). This process in which bacteria experience ROS as a byproduct of 
their metabolism can be called endogenous oxidative stress (Hassett and Cohen, 1986). On the other 
hand, the source of the ROS can also be exogenous, as when pathogenic bacteria are attacked by the 
host immune system and inflammation is induced (Hassett and Cohen, 1989). This is the scenario 
that Mtb is likely to face when it gets phagocytosed by an activated macrophage as discussed in 
section 1.
In order to fight oxidative stress bacteria have evolved some defenses, such as for example 
DNA and protein repair mechanisms and detoxifying enzymes (Hassett and Cohen, 1989). An 
efficient DNA repair mechanism, for example, can promptly identify a damaged site, remove it and 
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incorporate undamaged bases in its place (Kohen and Nyska, 2002). Table 3 shows examples of 
detoxifying enzymes. It is not clear why bacteria have multiple enzymes that are likely to be used to 
resolve excess peroxides in the cell, for example,  B. subtilis appear to have 9 potential peroxide 
scavenging enzymes in its genome (Broden et al, 2016).
Table 3: Mycobacterial defenses against Oxidative stress. Retrieved from Dussurget and Smith, 1998.
Is thought that iron deficiency may lead to elevation of oxidative stress levels in the cell due 
to decreased function of some of the protective enzymes, and bacteria may  face iron deficiency 
when infecting a host (Dussurget and Smith, 1998). In order to try to resolve the high levels of 
oxidative stress, the mycobacterial genome encodes enzymes like the superoxide dismutases 
(SODs) that are responsible for the conversion of superoxides to H2O2; the H2O2 is then converted to 
simpler organic peroxides by catalases and peroxidases like KatG (Dussurget and Smith, 1998).
Isoniazid can also be linked to increased oxidative stress in mycobacteria when we look at 
KatG function: (1) KatG is a catalase/peroxidase that will help resolve the high concentrations of 
H2O2 by converting it to simpler peroxides such as hydrogen peroxide, and (2) KatG will convert 
the INH prodrug to its active form which inhibits the mycolic acids synthesis (Dussurget and Smith, 
1998). It is believed that the INH conversion also generates ROS, which can contribute to the 
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degree of drug toxicity (Dussurget and Smith, 1998). It is postulated that INH will diffuse passively 
into the mycobacteria cell and KatG is not involved in the progdrug transport (Bardou et al., 1998). 
Once INH is inside the cell, KatG will promote a peroxidation reaction and "activate" INH, and this 
reaction will result in the production of oxygen radical species (Timmins and Daretic, 2006) which 
can then damage different components of the cell.
The mycolic acids of some pathogenic mycobacteria were  reported to have decreased 
sensitivity to lipid peroxidation due to cyclopropanation and this may be considered another defense 
against oxidative stress (Dussurget and Smith, 1998). When oxidized in the presence of NADH, 
INH will form the complex INH-NADH that inhibits the enzyme InhA, one of the major players in 
mycolic acids synthesis (Timmins and Daretic, 2006). INH is also capable of forming the complex 
INH-NADP when NADP+ is available and then inhibits the enzyme MabA in vitro, also known to 
be a key player in mycolic acid synthesis (Timmins and Daretic, 2006).
The presence of ROS are also reported to change the activation of different sigma factors, 
for example in Streptomyces coelicolor, where SigR activates the expression of a whole set of genes 
in response to oxidative stress (Touzain et al, 2008). In Mtb, SigH is considered the ortholog of 
SigR (Touzain et al, 2008). This suggests that SigH may also influence gene expression under 
oxidative stress conditions.
Li et al, 2015 analyzed the transcriptional response to H2O2 in M. smegmatis by using low 
and high concentrations of hydrogen peroxide in a similar manner as was done in the present study. 
Li et al, 2015 data also suggests that different sigma factors will regulate the response to different 
levels of oxidative stress inside the mycobacterial cell. It was  also shown that the protective 
enzymes mentioned earlier, such as katG and trx have increased  expression upon  exposure  to 
oxidative stress (Li et al, 2015).
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1.4. ROLES OF RNASE J IN MYCOBACTERIA
It was suggested that the major RNases responsible for RNA metabolism profile changes in 
bacteria are RNases E and J (Traverniti et al, 2011). And as discussed previously, RNase J is a non-
essential gene in Mtb and M. smegmatis (Traverniti et al, 2011). RNase J is also unique due to its 5' 
to 3' exoribonucleolytic activity as well as endoribonucleotic activity (Traverniti et al, 2011). Here 
the roles of RNase J in mycobacteria will be addressed in more depth.
In M.smegmatis RNase J is 558 amino acids in length and is encoded by the gene 
MSMEG_2685 (Traverniti et al, 2011). M. smegmatis RNase J can be classified as a β-CASP zinc-
dependent metallo-β-lactamase (Traverniti et al, 2011), and in this family of proteins the zinc is 
used to perform the cleavage reaction (Callebaut et al, 2002). The structure of RNase J from M. 
smegmatis, containing the β-CASP domain can be seen in Figure 6.
Figure 6: RNase J 3D structure from M. smegmatis (MSMEG_2685). Modified from (Traverniti et al, 
2011).
The β-CASP domain stands for metallo-β-lactamase-associated CPSF Artemis SNM1/PSO2 
and can be found in bacteria, eukaryotes and archaea (Callebaut et al, 2002). Some  metallo-β-
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lactamase proteins can use nucleic acids as substrates, including a subunit of the cleavage and 
polyadenylation specificity factor (CPSF) which is thought to take part in RNA cleavage, and other 
enzymes such as SNM1 from mice and PSO2 from yeast which play roles in DNA repair (Callebaut 
et al, 2002). Finally, Artemis which is also part of the metallo-β-lactamase group has been described 
as a recombination/DNA repair enzyme and can have exo and endonuclease activity depending on 
the complex it is linked to (Callebaut et al, 2002).
Among the proteins containing the β-CASP domain identified by Callebaut et al, 2002, it is 
worth noting the presence of Rv2752c from Mycobacterium tuberculosis and ML1512 from 
Mycobacterium leprae. Upon searching Rv2752c in the Tuberculist website 
(http://tuberculist.epfl.ch/index.html) it is possible to see that the ortholog for this gene in M. leprae 
is  ML1512 and in M. smegmatis the ortholog is MSMEG_2685, which is RNase J. This helps 
corroborate that Mtb and M. smegmatis have similar RNase J domain structures, suggesting the M. 
smegmatis may be a good model for studying the function of RNase J in Mtb.
Much of the work done to understand the roles of RNase J was done in Bacillus subtilis, 
which actually has RNase J1 and RNase J2 (Arraiano et al, 2010). RNase J1 was shown to be non-
essential in B. subtilis (Figaro et al, 2013) and prefers single-stranded 5' monophosphate ends as 
substrates for its exoribonuclease activity (Arraiano et al, 2010). RNase J1 and J2 are reported to 
from a complex but overall activity of RNase J2 is around 100 fold lower than RNase J1 activity 
(Figaro et al, 2013). The exoribonucleatic activity of RNase J1 was also reported to be responsible 
for the 16S rRNA maturation and regulation of some specific mRNA transcripts in Bacillus 
thuringiensis, including  the cryIIIA transcript which encodes for a insecticidal protein and the 
tryptophan operon (trp) (Arraiano et al, 2010).
When there is enough tryptophan in the cell, the TRAP (trp RNA-binding attenuation 
protein) complex binds to the transcript (Arraiano et al, 2010) and RNase J1 then cleaves this 
transcript between the TRAP complex and the transcription terminator (ter) (Condon, 2010). The 
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fragment upstream is then degraded by the PNPase enzyme while the fragment downstream of the 
cleavage site is degraded by RNase J1 exoribonucleatic activity (Condon, 2010). Figure 7 shows a 
graphical representation of the fate of the trp transcript in B. subtilis after endoribonucleotic activity 
of RNase J.
Figure 7: Fate of the trp transcript in B. subtilis after endoribonucleotic activity of RNase J. Reproduced 
from Condon, 2010.
Overall, in the case of B. subtilis, mRNA stability shows a small increase in the RNAse 
J1/J2 double deletion strain and these enzymes are considered to be functionally homologous to E. 
coli RNase E (Even et al, 2005). In Even et al., 2005 mRNA decay was measured by culturing early 
exponential phase cultures with 3H-uridine for a few minutes to label the mRNA. Transcription was 
then stopped and total RNA extracted in several time intervals; the  amount of mRNA present in 
each time point sample was then measured by the amount of radiolabelled uridine and the reported 
results showed a small increase in mRNA stability (Even et al, 2005). In B. subtilis, lack of RNase 
J1 was  also shown to cause growth defects, hypersensitivity to antibiotics and alterations in cell 
morphology that suggest defects in actin-like proteins (Figaro et al, 2013). In Staphylococcus 
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aureus, an RNase J deletion strain was reported to accumulate monophosphorylated 5' ends when 
compared to a WT strain (Linder et al, 2014). RNase J was  also reported to act in 16S rRNA 
maturation and takes part in both cleavage  of the transcript from RNase P in S. aureus and 
degradation of the 5' end of the initial transcript after cleavage (Linder et al, 2014).
In M. smegmatis, RNase J was shown to be responsible for  degrading 16S rRNA while 
RNase E is the enzyme responsible for the maturation of this transcript (Traverniti et al, 2011). For 
the 23S rRNA,  on the other hand, RNase J plays a major role in its maturation (Traverniti et al, 
2011) since an RNase J deletion strain had no detectable mature 23S rRNA in the cell (Traverniti et 
al, 2011). Finally, both RNase J and RNAse E were reported to be involved in maturation of the 5S 
rRNA (Traverniti et al, 2011). Since rRNA maturation in M. smegmatis was shown to be different 
from both E. coli, which does not have RNase J, and B. subtilis, where RNase E is not present 
(Traverniti et al, 2011), understanding the role of RNase J in mycobacteria might help reveal if and 
how RNase E and RNAse J functionally interact inside the cell and how this might influence stress 
survival in Mtb.
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2. PROJECT PURPOSE
This project has two main goals: (1) understand how oxidative stress conditions change 
RNA expression profiles in mycobacteria, and whether RNA cleavage contributes to these changes 
by influencing transcript stability and fate, and (2) understand the roles of RNase J in M. smegmatis 
and if this enzyme has any involvement in mycobacteria response to stress.
To achieve the first goal, RNA-seq expression libraries and 5' end mapping libraries were 
constructed under normal and oxidative stress conditions to investigate genes expression and 
transcript cleavage in M. smegmatis transcriptome wide.
In order to achieve the second goal, an RNase J knock out strain was created using 
recombineering strategy with homologous recombination, and compared with WT, overexpression 
and complemented strains. RNase J knockout  and  overexpression  strains were phenotypically 
analyzed by measuring drug resistance and stress tolerance. RNA-seq expression libraries were also 
constructed to analyze the effects of RNase J on gene expression transcriptome-wide.
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3. MATERIAL AND METHODS
3.1. STRAINS USED
This work was developed using the Mycobacteruim smegmatis strain mc2 155, referred to 
herein as WT strain, and  Escherichia coli DH5-alpha competent cells.
3.2. MEDIA PREPARATION
3.2.1. M. smegmatis MEDIA
3.2.1.1. MIDDLEBROOK 10x ADC SUPPLEMENT:
50g/L of BSA fraction V were dissolved in Milli Q water and agitated for at least 2 hours 
with low heat. Next 20g/L dextrose, 8.5 g/L NaCl and 30 mg/L catalase were added to the media 
and mixed with agitation for a few minutes. Media was filter sterilized and stored at 4 °C until use.
3.2.1.2. MIDDLEBROOK 10X ADS SUPPLEMENT (FOR OXIDATIVE STRESS 
EXPERIMENTS):
50g/L of BSA fraction V were dissolved in Milli Q water and agitated for at least 2 hours 
with low heat. Next 20g/L dextrose and 8.5 g/L NaCl were added to the media and mixed with 
agitation for a few minutes. Media was filter sterilized and stored at 4 °C until use.
3.2.1.3. MIDDLEBROOK 7H9 BROTH
4.7 g/L of 7H9 Broth powder, 0.25% of the final solution volume of 20% Tween 80, 0.4 % 
of the final solution volume of 50% glycerol and 10%  of the final solution volume of 10x ADC or 
ADS were dissolved in Milli Q water with agitation for a few minutes. Media was then filter 
sterilized and stored at 4 °C until use.
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3.2.1.4. MIDDLEBROOK 7H10 AGAR
19 g/L of 7H10 Agar powder was mixed with Milli Q water and 1% of the final solution 
volume of 50% glycerol and mixed for a few minutes. Media was then autoclaved 20 minutes at 
121 °C and when medium cooled down 100 mL ADC was added and antibiotic if needed. 25 mL of 
media was then poured in each petri dish and when solid stored at 4 °C until use. In the case of 
square plate 35 mL per plate is used.
3.2.2. E. coli MEDIA
3.2.2.1. LB BROTH
25 g/L of LB Broth powder was dissolved on Milli Q water and mixed until complete 
dissolution of the powder. Media was autoclaved 20 minutes at 121 °C and stored in room 
temperature until use.
3.2.2.2. LB AGAR
40 g/L of LB Agar powder was dissolved on Milli Q water and mixed until complete 
dissolution of the powder. Media was autoclaved 20 minutes at 121 °C and stored in room 
temperature until use.
3.3 DNA AND RNA ISOLATION FROM MYCOBACTERIA
3.3.1. DNA ISOLATION FROM MYCOBACTERIA
Unless noted, all centrifugation steps were done at room temperature.
5 mL to 10 mL of liquid culture in log phase were centrifuged at 4000 rpm for 5 minutes and 
cells were ressuspended in 200 μL of TE Buffer (10 mM Tris pH 7.5 and 1 mM EDTA) and 
transferred to a beat-beating tube (MP Biochemicals lysing matrix B, product #6911-500). 400 μL 
phenol:chloroform:isoamyl alcohol (25:24:1) pH 8 was added to each tube and the tubes were 
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vortexed for a couple minutes in order to break the cell envelopes. Samples were then centrifuged at 
14000 rpm for 5 minutes and the upper aqueous layer was transferred to a new tube.
1 mL of ice-cold ethanol (95%-100%) was added to each sample and mixed gently. Samples 
were then centrifuged at 14000 rpm for 5 minutes at 4 °C, the supernatant was aspirated off and 1 
mL of 70% ethanol added to wash the samples.
After the wash samples were centrifuged at 14000 for 5 minutes at room temperature and 
ethanol was aspirated off. Tubes were then centrifuged one more time at 14000 for 30 seconds and 
any residual ethanol was removed with a pipet.
The pellet was dryed with the tubes open for a few minutes and 100 μL of ultra pure water 
added to ressuspend the samples. Finally, DNA concentration was measured using NanoDrop® and 
samples stored in -20 °C until use.
3.3.2. TOTAL RNA EXTRACTION FROM MYCOBACTERIA
5 mL to 10 mL of liquid culture with OD between 0.5 to 1 were centrifuged at 4000 rpm for 
5 minutes at 20 °C. Supernatant was then removed without disturbing the pellet and resuspend in 1 
mL TRIzol (Invitrogen). Samples were transferred to bead-beating tubes (MP Biochemicals lysing 
matrix B, product #6911-500) and bead-beat in the FastPrep 5G twice for 40 seconds at 9 msec, 
placing samples on ice for 2 minutes in between.
300 μL chloroform was added to each sample and mixed and samples were centrifuged at 
15000 rpm for 15 minutes at 4 ºC. Aqueous layer was then pipeted and added to a new tube 
containing 600 μL isopropanol and mixed. Sample tubes were left in -20 °C freezer for 45 minutes 
to overnight.
After the -20 °C incubation, samples were centrifuged at 15000 rpm for 10 minutes at 4 ºC 
and the supernatant was poured off. 1 mL 75% ethanol was added and the tubes were gently 
inverted several times to wash the pellet. Samples were centrifuged again for 1 minute at 15000 rpm 
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at 4 ºC and supernatant was poured off.
Samples were then centrifuged again briefly to bring liquid to bottom of tube and the 
remaining supernatant was pipetted off. Tubes were allowed to stay at room temperature with lids 
closed for 10 minutes and any remaining supernatant was removed.
Pellets were ressuspended in 100 µL of ultra pure RNase-free water, RNA concentration was 
then measured using NanoDrop® and samples were stored at -80 ºC  until use.
3.3.3. DNASE TREATMENT
In order to minimize DNA contamination in RNA extraction samples, a maximum of 20 µg 
of RNA was treated with 2.5 µL Ambion DNase Turbo enzyme, 10 µL of 10x DNase buffer and 
ultra pure RNase-free water to a final volume of 100 µL. Samples were then incubated for 1 hour at 
37 °C with gentle agitation. After DNase treatment proceed to RNA clean up.
3.3.4. RNA CLEAN UP
All centrifugation steps were done in room temperature and samples were stored in -80 °C 
until use.
To start the procedure, RNA samples had their volume adjusted to 100 µL with RNase-free 
water if needed then 350 µL RTL buffer was added to each sample. Following, 250 µL of ethanol 
(96-100%) was added to each sample and mixed well by pipeting. Samples where then transferred 
to an RNeasy® column and centrifuged for 15 seconds at 15000 rpm. The flow-through was 
discarded and 500 µL RPE buffer to each sample to wash the membrane. After 15 seconds 
centrifugation at 15000 rpm, the flow-through was once again discarded and the wash was repeated.
A third wash step was performed by adding 500 µL RPE buffer and samples were 
centrifuged for 2 minutes at 15000 rpm. Samples were then transferred to a 2 mL new collection 
tube provided by the manufacture and centrifuged at 15000 rpm for 1 minute to collect any 
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remaining buffer. Samples were placed in a clean 1.5 mL collection tube and between 50 µL to 100 
µL of RNase-free water was added to the columns, depending on the expected yield. Samples were 
centrifuged at 15000 rpm for 1 minute to elute the RNA.
3.4. OXIDATIVE STRESS EXPRESSION AND 5' END MAPPING LIBRARIES 
PREPARATION
Using the oxidative stress media containing ADS as supplement, WT strain was thawed 
from the -80 °C frozen stock and cultured for 1 day. On the next day cells were diluted and were 
grown overnight to reach OD600 of approximately 0.8. Cultures were diluted to OD 0.15 and 
incubated in triplicate with different mM concentrations of hydrogen peroxide for 9h with OD600 
measurements taken at every 3h.
Once the hydrogen peroxide concentration for library construction (3.2 mM) was chosen, 
cells were again grown using the same method as described above and harvested at 3h and 6h for 
library construction. After total RNA extraction of the samples as previously stated, an RNA clean 
up procedure were performed in the cells followed by a DNase treatment and another RNA clean 
up.
To start with the libraries procedure, 6 out of the 9 harvested samples were chosen. The 
samples used for this assay can be seen on the following table:
Table 4: Oxidative Stress experiment samples used for library construction
Condition Replicates
Control – no H2O2 3h 1 and 2
3.2 mM H2O2 3h 1 and 2
3.2 mM H2O2 6h 1 and 3
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3.4.1. OXIDATIVE STRESS EXPRESSION LIBRARIES
To construct the expression libraries the Epicentre ScriptSeqTM Complete kit for bacteria was 
used following the manufacturer's recommendations as shown in the next sections:
3.4.1.1. rRNA DEPLETION
For this procedure we used the batch washing protocol to prepare the beads for use. For each 
of the 6 samples 225 µL of magnetic beads were used.
The total of 1350 µL of magnetic beads were placed into a clean microcentrifuge tube and 
then placed into a magnetic stand for 1 minute so the solution turned clear. The supernatant was 
discarded and 1350 µL of RNA-free water was added to the tube to wash the beads. Samples were 
mixed at medium speed and placed on the magnetic stand. The supernatant was removed and the 
wash step repeated on more time.
The tube was then removed from the magnetic stand and 360 µL of Bead Resuspension 
Solution was added. Samples were mixed at medium speed and divided into 65 µL aliquots. 1 µL of 
Riboguard RNase Inhibitor was added to each aliquot and tubes were stored in room temperature 
until use.
As the washed magnetic beads were waiting at room temperature the volumes containing 5 
µg of RNA for each sample were calculated and combined with RNase-free water for a total of 26 
µL per sample. To each sample 4 µL of Ribo-Zero Reaction Buffer and 10 µL of Ribo-Zero rRNA 
Removal Solution were added for a final volume of 40 µL per sample. The reaction were mixed by 
pipeting and incubated at 68 °C for 10 minutes followed by a 5 minute incubation at room 
temperature.
The treated RNA samples were then mixed with the magnetic beads by pipeting and then 
mixed by vortexing for 10 seconds. The tubes were incubated as room temperature for 5 minutes 
and then mixed by vortexing for 10 seconds one more time. Samples were incubated at 50 °C for 5 
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minutes and immediately placed in a magnetic stand for at least 1 minute until the solution become 
clear. The supernatant, containing the rRNA-depleted samples were transferred to new micro 
centrifuge tubes and ut through a purification procedure.
Before starting the purification, sample volumes were adjusted to 180 µL using RNase-free 
water. Then 18 µL of 3 M sodium acetate and 2 µL glycogen were added to each sample and gently 
mixed. 600 µL ice-cold 100% ethanol was added to each sample and mixed gently and the samples 
were placed in -20 °C for at least 1 hour.
After the 1 hour incubation samples were centrifuged at 15000 rpm for 30 minutes at 4 °C 
and the supernatant was discarded. The pellet was washed twice with ice-cold 70% ethanol and 
centrifuged at 15000 rpm at 4 °C. After carefully removing the supernatant from the second wash, 
samples were centrifuged for an extra minute to collect any residual ethanol and any remaining 
supernatant was discarded. The samples were allowed to stay at room temperature for 5 minutes and 
the pellet was dissolved in 10 µL RNase-free water. If not used immediately, samples were stored in 
-80 °C.
3.4.1.2. RNA FRAGMENTATION, cDNA SYNTHESIS AND TERMINAL-TAGGING
After rRNA depletion, 2 µL of the treated sample was mixed with 7 µL RNase-free water, 1 
µL RNA fragmentation solution and 2 µL of cDNA synthesis primer to fragment the RNA and 
anneal the cDNA synthesis primer. The samples were incubated at 85 °C for 5 minutes and the 
fragmentation was stopped by placing the tubes in an ice-water bath.
Next, a cDNA synthesis reaction was prepared by mixing with  each sample 3 µL cDNA 
synthesis PreMix, 0.5 µL 100mM DTT and 0.5 µL StartScript reverse transcriptase. Samples were 
then incubated at 25 °C for 54 minutes followed by an incubation at 42 °C for 20 minutes using a 
thermocycler. The reaction was equilibrated to 37 °C and 1 µL of finishing solution was added to 
each sample and mixed by pipeting. Samples were then incubated at 37 °C for 10 minutes followed 
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by 3 minutes at 95 °C. Once the incubation was finished, samples were equilibrated to 25 °C and 
had 7.5 µL terminal tagging premix and 0.5 µL DNA polymerase added. Samples were mixed by 
pipeting and incubated at 25 °C for 15 minutes followed by 3 minutes at 95 °C. Samples were 
equilibrated at 4 °C until the purification step was initiated.
For this purification step the columns from the MinElute kit from Quiagen were used. 125 
µL of buffer PB were added to each sample and the final solution was transferred to a labeled 
MinElute column. To bind the cDNA, the columns were centrifuged for 1 minute at 14000 rpm. 
After the flow-through was discarded, 750 µL buffer PE was added to wash the samples and they 
were centrifuged for 1 minute at 14000 rpm. This wash step was repeated on more time and after 
the flow-through was discarded, the samples were centrifuged for an extra minute at 14000 rpm to 
remove any residual ethanol from buffer PE.
Columns were placed in clean microcentrifuge tubes and 25 µL buffer EB was added to 
elute the cDNA and samples were centrifuged for 1 minute at 14000 rpm. Samples were stored at 
-20 °C until use.
3.4.1.3. ADDING THE INDEXES AND FINAL LIBRARY PURIFICATION
22.5 µL of the purified di-tagged cDNA from the previous steps was mixed to 25 µL 
FailSafe PCR PreMix E, 1 µL forward PCR primer, 1 µL unique Script Seq Index PCR primer 
(reverse) and 0.5 µL FailSafe PCR enzyme. The PCR was done in two batches of 3 samples each 
where each batch contained one replicate of each condition. For the first batch we used 12 PCR 
cycles and for the second 14 cycles were performed. The conditions are as it follows: 3 minutes at 
95 °C to denature the DNA, 12 or 14 cycles with 95 °C for 40 seconds, 55 °C for 30 seconds and 68 
°C for 3 minutes and a final incubation using 68 °C for 7 minutes. The following table shows which 
unique index was used for each sample, and the sequences for the respective indexes can be found 
in section 6.1. of the Appendix.
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Table 5: Unique Indexes used for Oxidative stress expression library construction
Sample Unique Index
Control 3h replicate 1 Epicentre Kit Index 7
Control 3h replicate 2 Epicentre Kit Index 8
3.2mM H2O2 3h replicate 1 Epicentre Kit Index 9
3.2mM H2O2 3h replicate 2 Epicentre Kit Index 10
3.2mM H2O2 6h replicate 1 Epicentre Kit Index 11
3.2mM H2O2 6h replicate 3 Epicentre Kit Index 12
After the PCR samples were purified using the Agencourt AMPure XP Magnetic  Beads 
purification method. Initially, AMPure XP beads were allowed to warm to room temperature and 50 
µL of the beads solution were added to each sample and mixed thoroughly by pipeting. The total 
volume of sample (100 µL) was transferred to a clean microcentrifuge tube and incubated at room 
temperature for 15 minutes. Samples were then placed in a magnetic stand and incubated at room 
temperature for 5 minutes until the liquid appeared clear.
The supernatant was removed and discarded and the tubes which were still located  in the 
magnetic stand were washed twice  with 200 µL of 80% ethanol for 30 seconds. The beads were 
allowed to air dry on the magnetic stand for 15 minutes at room temperature and the tubes were 
removed from the stand after 20 µL nuclease-free water was added to the samples. The beads were 
resuspended by pipeting and incubated in room temperature for 2 minutes and placed again in the 
magnetic stand for at least 5 minutes until the liquid appeared completely clear. The supernatant, 
which contained the finalized library, was transferred to a new tube, DNA concentration was 
measured using QuBit and samples stored in -20 °C until the start of the sequencing procedure.
The following figure shows an overview of the library construction procedure used.
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Figure 8: Overview of the oxidative stress expression library preparation.
3.4.2. OXIDATIVE STRESS 5' END MAPPING LIBRARIES
rRNA depleted samples from section 3.4.1.1 were also used for construction of 5' end 
mapping libraries. Libraries were constructed essentially as described in Shell et al., 2015, with 
details below.
3.4.2.1. DEPHOSPHORYLATION AND DNA-RNA HYBRID LIGATION
For each one of the rRNA-depleted samples we used a total of 6 µL: 3 µL for the converted 
library and 3 µL for the non-converted library. For the converted library, which was the one where 
the dephosphorylation occurred, we combined 3 µL of rRNA-depleted sample, 2 µL 10X Buffer, 1 
µL 5' Polyphosphatase and 14 µL RNase-free water. For the non-converted library, 1 µL water  was 
substituted for the 1 µL of 5' Polyphosphatase enzyme. All 12 samples were incubated at 37 °C for 
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1 h and then purified using the RNA clean up as described in section 3.3.4. with only changing the 
elution step. Instead of using 50 µL RNase-free water, for this step samples were eluted twice using 
30 µL of water containing RNase OUT (10 µL in 1 mL of water) and DTT (10 µL in 1 mL of water) 
for a final volume of 60 µL. After purification, 1 µL 100 mM Tris pH 7.5 was added to each sample 
and they were concentrated to 8 µL using a speedvac centrifuge.
1 µL of oligo SSS392 1 µg/µL (DNA-RNA hybrid adapter) was added to each sample and 
they were incubated for 10 minutes at 65 °C and snap-cooled in an ice-water bath once the 
incubation period was over. In sequence, the following was added to each sample: 1 µL RNase 
OUT, 10 µL 50% PEG 8000, 3 µL 10X T4 RNA ligase I buffer, 3 µL 10 mM ATP, 3 µL DMSO and 
1 µL T4 RNA ligase I. Samples were then incubated at 20 °C overnight. On the next day, samples 
were purified using the RNA clean up as described in section 3.3.4 and concentrated to 5 µL using a 
speedvac centrifuge.
The following figure shows how the dephosphorylation happens in the 5' end and which 
structures (transcription start sites and cleavage sites) each library construction will capture since 
the enzyme T4 RNA ligase used in this procedure is only able to act in a 5' monophosphate.
Figure 9: How to differentiate between a transcription start site and a cleavage site based on their 5' end 
structures and set ups for the converted (dephosphorylation) and non-converted (no treatment) libraries.
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3.4.2.2. RNA FRAGMENTATION AND FIRST STRAND cDNA SYNTHESIS
The 5 µL  samples with DNA-RNA adapter ligated had 4 µL 5X NEBNext first strand 
synthesis reaction buffer and 1 µL random primers SSS397 (1 µg/µL) added and samples were 
heated at 94 °C for 11 minutes in a pre heated thermocycler in order to fragment the RNA. After the 
incubation samples were snap-cooled in an ice-water bath.
To perform the first strand cDNA synthesis, the following was added to each sample: 0.5 µL 
murine RNase inhibitor, 0.5 µL Actinomycin D (0.1 µg/µL), 1 µL II ProtoScript Reverse 
Transcriptase and 3.5 µL RNase-free water. Next, the samples were incubated at 25 °C for 10 
minutes, followed by a 42 °C incubation for 50 minutes and 15 minutes at 70 °C. 10 µL 1 N NaOH 
and 10 µL 500 mM EDTA were added to each of the 12 samples and they were incubated at 65 °C 
for 15 minutes to degrade any remaining RNA present in the samples.
25 µL 1 M Tris pH 7.5 was added to each sample and samples were purified using MinElute 
columns according to the following protocol: 600 µL PB buffer were added to each reaction and 
mixed by pipeting. Samples were applied to a MinElute column and centrifuged for 1 minute at 
14000 rpm to bind the cDNA. The flow-through was loaded in the columns one more time and the 
centrifugation step was repeated to increase the final yield of cDNA that was binding the column. 
Flow-through was then discarded and 750 µL PE buffer was added to wash the columns and 
samples were centrifuged for 1 minute at 14000 rpm. This wash step was repeated for all samples 
and the flow-through was discarded. Samples were then centrifuged for another minute at 14000 
rpm to eliminate any residual PE buffer. Columns were then placed in clean microcentrifuge tubes 
and cDNA eluted  in 30 µL RNase-free water by 1 minute centrifugation at 14000 rpm. The elution 
step was then repeated with another 30 µL water for a final volume of 60 µL per sample.
After purification samples were concentrated to 14.1 µL using a speedvac centrifuge.
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3.4.2.3. PCR TO ADD INDEXES AND FULL-LENGTH ILLUMINA ADAPTERS
Using the 14.1 µL samples from the previous step, PCR reactions were performed to add the 
unique index to each sample. In a clean tube the following were combined with the 14.4 µL cDNA 
sample: 10 µL 5X GC Phusion Buffer, 2.5 µL 10 mM Forward primer (SSS398), 20 µL  5M 
Betaine, 0.5 µL Phusion polymerase, 0.4 µL dNTP mix (25 mM each) and 2.5 µL10 mM Reverse 
unique index primer. The samples were then moved to a thermocycler using the following 
conditions: 98 °C for 3 minutes, 12 cycles with 98 °C for 80 seconds, 60 °C for 30 seconds and 72 
°C for 30 seconds  and a final extension incubation at 72 °C for 5 minutes. The following table 
shows which unique reverse index primer was used for each sample:
Table 6: Unique indexes used for 5' end mapping library construction and sample differentiation.
Sample Unique index Index sequence
Control 1 - 3 h - non-converted library SSS 399 CGTGAT
Control 1 - 3 h - converted library SSS 403 GCCTAA
Control 2 - 3 h - non-converted library SSS 651 ATTGGC
Control 2 - 3 h - converted library SSS 653 GGACGG
3.2 mM 1 - 3 h - non-converted library SSS 654 CTCTAC
3.2 mM 1 - 3 h - converted library SSS 655 GCGGAC
3.2 mM 2 - 3 h - non-converted library SSS 656 TTTCAC
3.2 mM 2 - 3 h - converted library SSS 657 GGCCAC
3.2 mM 1 - 6 h - non-converted library SSS 658 CGAAAC
3.2 mM 1 - 6 h - converted library SSS 659 CGTACG
3.2 mM 3 - 6 h - non-converted library SSS 660 CCACTC
3.2 mM 3 - 6 h - converted library SSS 661 GCTACC
After the PCR, samples were purified using the Agencourt AMPure XP Magnetic Beads 
purification following the guidelines as described: the magnetic AMPure Beads were allowed to 
equilibrate to room temperature and mix 1.2 volumes (60 µL) beads per volume DNA (50 µL) by 
pipeting at least 10 times. Each sample were then transferred to a clean microcentrifuge tube and 
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incubated for 15 minutes at room temperature. Tubes were then places in a magnetic stand and 
incubated for at least 5 minutes until the liquid became clear and the supernatant was discarded. 
With the tubes still on the magnetic stand, beads were washed 2 times with 200 µL of 80% ethanol 
for 30 seconds and the supernatant was discarded. Tubes were allowed to air dry with the caps 
opened for 10 minutes on the magnetic stand. Beads were removed from the magnetic stand and 
resuspended in 50 µL RNase-free water. After incubate the cell at room temperature for 2 minutes, 
tubes were place again in the magnetic stand for 5 minutes. The clean supernatant, which contains 
the libraries, were transferred to clean tubes and DNA concentration was measured using QuBit.
Since the samples concentrations were lower than expected and the QuBit was not able to 
measure then,  samples were concentrated to 14.1 µL using the speedvac centrifuge and more PCR 
cycles performed to enrich for full-length products. For this PCR reaction, the 14.1 µL samples 
were mixed with 10 µL 5X GC Phusion Buffer, 2.5 µL 10 µM primer SSS 401, 2.5 µL 10 µM 
primer SSS 402, 20 µL 5 M Betaine, 0.4 µL 25 mM each dNTP mix and 0.5 µL Phusion 
polymerase by pipeting. Followed the same condition as the previous PCR, a further 8 cycles were 
performed in the samples by using a thermocycler. Samples were then purified again using the 
AMPure purification procedure as previously stated with the difference that instead of 1.2 volumes 
of beads, it was used 1.8 volumes (90 µL) of beads.
DNA concentrations were measured by QuBit and libraries were stored at  -20 °C until the 
start of the sequencing procedure.  The following figure shows an overall procedure for the 5' end 
mapping library construction.
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Figure 10: Overview of the oxidative stress 5' end mapping library preparation.
3.5. RNASE J KNOCKOUT CONSTRUCTION AND COMPLEMENTATION
Figure 11 shows a graphic representation of the procedures that discussed in the next 
sections.
Figure 11: Overview of KO construction and complementation.
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3.5.1. KNOCKOUT CONSTRUCTION
In order to knockout RNase J homologous recombination was used to replace the RNase J 
coding sequence with a hygromicin resistence gene. The RNase J sequence and also its neighbor 
upstream and downstream sequences were retrieved from the Smegmalist website.
Using SeqBuiderTM software for DNA sequence visualization primer sets were constructed 
to amplify a region with 500 nucleotides upstream (primer SSS 589 and SSS 590) and 500 
nucleotides downstream (primers SSS 591 and SSS 592) of the RNase J coding sequence. Genomic 
DNA extracted from M. smegmatis strain mc2 155 was used as template for these PCRs.
To amplify the hygromicin resistance gene, the plasmid pMV762 was used a template with 
primers SSS 584 and SSS 583. A PCR using primers SSS 598 and SSS 583 was then performed to 
connect the upstream flank with the hyg resistance gene and, last, a PCR using primers SSS 589 and 
SSS 592 was performed to connect together upstream flank, hyg resistance gene and downstream 
flank to form the final construct. For these PCRs, Q5 DNA polymerase was used due to its low 
error  rate  and the  primers  Tm and annealing temperatures  were calculated using  the  NEB Tm 
calculator available at http://tmcalculator.neb.com/#!/.
Mycobacteria in general have a low DNA uptake and a low homologous recombination rate, 
which makes challenging to manipulate their genomes (Van Kessel and Hatfull, 2008). In order to 
increase recombination rates a strategy known as recombineering can be used, which consists in use 
a plasmid containing mycobacteriophage recombination genes (Van Kessel and Hatfull, 2008).
Once enough construct (around 2 µg DNA) was made, we used the following protocol to 
prepare M. smegmatis competent cells using a WT strain which was previously tranformed with a 
recombinase plasmid pJV53 (Van Kessel and Hatfull, 2008).
50 mL of liquid cultures were grown overnight with OD600 between 0.6 to 1 with 50 µL the 
recombinase plasmid inducer (inducer solution was made by adding 0.8 µL Isovaleronitrile in % 
mL DMSO). Culture was transferred to conical tubes and centrifuged for 5 minutes at room 
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temperature using 4000 rpm. The supernatant was discarded and the pellet washed with 50mL 10% 
glycerol and centrifuged for 10 minutes at room temperature using 4000 rpm. Supernatant was 
discarded and the wash step repeated one more time.
The pellet was then ressuspended in 5ml of 10% glycerol and centrifuged again using the 
same conditions as before. The supernatant was once again discarded and the pellet was 
ressuspended in 300 µL 10% glycerol. Ressuspended cells were divided in 50 µL aliquots and used 
for transformation. Aliquots not used immediately were frozen by contact with a solution containing 
dry ice and 95% ethanol and stored at -80 °C.
Next, following the protocol, an aliquot of competent cells was mixed with the knockout 
construct (around 2 µg) of interest and transferred to a 2mm electroporation cuvette. Cells were 
electroporated using E. coli settings for the 2 mm cuvette and then transferred to a clean 
microcentrifuge tube containing 200 µL of 7H9 media. Cells were incubated with shaking at 37 °C 
for 4 hours to recover from transformation and then plated in 7H10 plates containing the selective 
antibiotic.
After a few days of incubation, 12 colonies were visible in the plate. They were each picked 
and cultured in liquid media without any antibiotic in order to facilitate the strains to lose the 
recombinase plasmid. 100 µL of the cell culture and 1/10 and 1/100 dilutions were then plated on 
7H10 agar containing 15% sucrose to select for the cultures that lost the plasmid. The recombinase 
plasmid has the SacB gene which makes sucrose toxic to the cell and then ideally they will not 
grown in media containing sucrose.
Using the colonies from the sucrose plates a second selection was done  in  which  the 
colonies were streaked in plates containing kanamycin (the selection drug for the plasmid), then 
plates containing sucrose and 7H10 plates with no drug. Cells which lost the plasmid should grow 
on the sucrose and no drug plates only. The knockout strains were then validated by PCR with 
primers SSS 593 and SSS 594 with anneal "outside" of the knockout construct and the colonies with 
33
the correct size were sent to sequencing to further check the nucleotide sequence surrounding the 
integration site. 
3.5.2. COMPLEMENTING THE KO STRAIN
The next step was to construct a complementation vector to restore the RNase J activity in 
the KO strain. A complementation construct was built using the RNase J coding sequence,  a 
synthetic ribosome binding site and the MOP promoter. The construct was amplified using the 
primers SSS 644 and SSS 645.
Plasmid pJEB402 was cut with Puv II and Hind III restriction enzymes and a Gibson 
Assembly reaction was performed to combine the vector backbone with the complementation 
construct as stated in the following protocol:
1.5 µL of vector backbone and 3.5 µL of insert were mixed together in a 0.2 mL tube. Five 
µL of Gibson assembly 1 step master mix (2x) was added to the sample and it was incubated for 1 
hour at 50 °C. 2 µL were used for the E. coli transformation and the remaining solution was stored 
at -20 °C.
A tube of NEB 5- α competent cells was thawed on ice for 10 minutes and had 2 µL of the 
Gibson Assembly solution added to it. The cells were  then placed on ice for 30 minutes without 
mixing. Next, cells were submitted to a heat shock at 42 °C for 30 seconds and then placed on ice 
for another 5 minutes. Cells were then resuspended in 200 µL of SOC rich media and incubated 
with 250 rpm shaking at 37 °C for 1 hour. Last, 20 µL and 200 µL of cells were plated in LB 
containing kanamycin and incubated overnight at 37 °C.
A few colonies were chosen and grown in liquid LB with kanamycin for a day and then a 
Miniprep (Qiagen®) reaction was performed following the instructions from the manufacturer in 
order to isolate the plasmid.
Next competent cells from the M. smegmatis KO strain were made and transformation 
proceeded as stated in section 3.5.1. A transformation with the WT was done following the same 
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protocol in order to obtain the overexpression strain (WT+J).
To obtain the strains JKO+E and WT+E, RNase J KO and WT strains respectively were 
transformed using the empty backbone vector before the insertion of RNase J coding sequence 
(pJEB402).
This particular vector has a promoter called MOP which is a strong synthetic constitutive 
promoter designed specifically for mycobacterial cells (Fortune et al, 2005).
3.6. RNASE J STRAINS PHENOTYPIC ASSAYS
3.6.1. qPCR TO DETERMINE THE RELATIVE EXPRESSION LEVEL
To determine the relative expression level for the WT+E, WT+J, JKO+E and JKO+J strains 
cells were cultured and had their total RNA extracted as stated in section 3.3.2. followed by a 
DNase treatment and RNA clean up as stated in sections 3.3.3. and 3.3.4.
After concentrations for the samples were measured, the volume necessary for 1 µg RNA for 
each sample was calculated and transferred to a clean tube. RNase-free water was used to complete 
a final volume of 5.25 µL per reaction. This samples were also tested for genomic DNA 
contamination using a no-RT (reverse transcriptase) control.
0.5 µL 100 mM Tris and 0.5 µL 1 mg/mL random hexamers were added to each sample and 
mixed by pipeting. Samples were incubated for 10 minutes at 70 °C and snapped-cool in an ice 
water bath. Next, 2 µL 5X First strand buffer, 0.5 µL 10 mM each dNTP, 0.5 µL 100 mM DTT, 0.25 
µL RNase OUT and 0.5 µL Superscriptt III reverse transcriptase was added to each test sample. For 
the no-RT samples, 0.5 µL RNase-free water was added instead of Superscriptt III reverse 
transcriptase. All samples were then incubated at 25 °C for 5 minutes, 50 °C for 2 hours and 70 °C 
for 15 minutes.
After the incubation, samples had 5 µL 0.5 M EDTA and 5 µL NaOH added and were 
incubated for 15 minutes at 65 °C. Next, 12.5 µL 1 M Tris was added to each sample and then were 
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purified using Quiagen MinElute columns following the procedure as stated:
500 µL PB buffer was added to each sample and mixed by pipeting. Samples were 
transferred to labeled MinELute columns and centrifuged at 14000 rpm for 1 minute to bind the 
cDNA to the columns. Flow-through was discarded and 750 µL PE buffer was added to wash the 
samples. Samples were centrifuged  at 14000 rpm for 1 minute and flow-through discarded. 
Samples  centrifuged again at 14000 rpm for 1 minute to eliminate any residual buffer from the 
columns. Columns were transferred to clean microcentrifuge tubes and 50 µL EB buffer added to 
elute the cDNA. Columns were centrifuged at 14000 rpm for 1 minute and cDNA concentrations 
were measured using a Nanodrop. The samples without RT (no-RT) should have significant lower 
concentration than test samples to corroborate that there is low to none genomic DNA 
contamination. Samples were stored on -20 °C until use.
Meanwhile, IDT’s primer quest tool was used to design three set of primers to amplify 
RNase J coding sequence retrieved from Smegmalist. Primers sets were then tested using WT strain 
cDNA and comparing with validation primers JR273 and JR274. WT cDNA was diluted to 200 
pg/µL, 40 pg/µL, 8 pg/µL and 1.6 pg/µL using RNase-free water. Primer sets, on the other hand, 
were diluted together with their pairs using RNase-free water to a final concentration of 2.5 mM 
each primer. Each cDNA concentration were tested in  technical triplicates by adding to each well 
of the 96 well PCR plate: 2 µL primer set mix, 10 µL Taq universal SybrGreen Supermix, 6 µL 
water and 2 µL cDNA. Water controls were also performed to address amplicon contamination in 
the water stock. The plate with the final samples was then ran in an  Applied Biosystems 7500 qPCR machine using the following cycle conditions: 50 °C for 2 minutes, 95 °C for 10 minutes and 40 cycles using 95 °C for 15 seconds and  61 °C for 1 minute. The machine was set to  standard curve assay type with 20  µL per reaction and the melt curve was included to address 
quality of the primers annealing.  Data for the primers tested and their efficiency values can be 
found in Appendix 7.2. For analysis proposes a CT threshold of 0.2 was used and efficiency was 
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calculated based on the equation 10^(-1/slope) –  1. Based on the data analysis, the primer set 
SSS706-707 was chosen to perform the relative expression qPCR.
To address the relative expression for the WT+E, WT+J, JKO+E and JKO+J strains, 40 pg 
cDNA per reaction was used. For these experiments were used 3 biological replicates per strains.
Samples cDNA were diluted to 20 pg/µL using RNase-free water and for each well of the 96 
well  PCR plate  was  added  2  µL 2.5  mM  each  primer  mix,  10  µL Taq  universal  SybrGreen 
Supermix,  6  µL water  and 2  µL cDNA. For  the  water  control  samples  the  2  µL cDNA were 
substituted by RNase-free water. Cycling conditions and machine settings were the same as used for 
testing the primers, with the exception that the melt curve was not included for this reaction. For 
data analysis the  ΔCT method was used to compare the CT obtained with the SSS706-707 primers 
and the CT obtained with the validation primers (JR274-274). Relative expression level was then 
determined by the formula: 2- ΔCT.
3.6.2. MINIMAL INHIBITORY CONCENTRATION
Late log OD600 cultures (between 0.6 and 1) were diluted to OD600 0.002 and set aside until 
use. Meanwhile the antibiotic of interest was dissolved in 7H9 in a concentration 4 times higher 
than the higher concentration to be tested on the plate.
A 96 well plate was obtained and 100 µL of drug-free 7H9 liquid media was added to each 
well. Next, 100 µL of the previously dissolved drug was added to the top row of the plate and 
mixed well by pipeting. A 2 fold serial dilution was then performed so the next row would always 
have half as much drug concentration than the previous row. For the last row when the serial 
dilution took place, 100 µL of media was discarded.
100 µL of the bacterial stock previously diluted was then added to each well and mixed by 
pipeting. Plate was covered with a breathable film and incubated for 24 h at 37 °C with 125 rpm 
shaking. Once the first 24 h incubation was done, a resazurin solution with 0.02% (w/v) in destilled 
37
water was prepared and filter sterilized and 20 µL of this solution was added to each well of the test 
plate. After resazurin was added, the plate was covered with breathable film and incubated for 20 to 
24 h at 37 °C with 125 rpm shaking.
The resazurin when its oxidized form is a blue dye and turns pink when it is reduced to 
resorufin, which is a pink dye, when viable cells are grown aerobically (Taneja and Tyagi, 2007).
The minimal inhibitory concentration (MIC) is defined as the lowest drug concentration 
were no change in resazurin color occurred. The following figure shows an overview of the MIC 
assay procedure: 
Figure 12: Overall procedure to run a MIC (Minimal Inhibitory Concentration) assay using a well plate.
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3.6.3. ANTIBIOTIC KILLING ASSAYS
Cells where grown in 7H9 liquid media until reach late log phase (around OD600 0.6 - 1) and 
then adjusted to OD600 0.1. 3 mL of media were added to each 15 mL conical tube and the drug in 
the  tested concentration was added to half of then. Tubes were then incubated for 24h at 37 °C with 
250 rpm shaking. In parallel, 200 µL of the OD600 0.1 samples were used to performed a 10 fold 
serial dilution and 5 µL of all dilutions were spotted in squared shaped 7H10 plates in triplicates 
and incubated at 37 °C for 3 days. These plates are addressed as input CFU.
After the 24 h incubation the tubes are removed from the incubator and centrifuged at 4000 
rpm for 5 minutes at room temperature. The supernatant is discarded and pellet is ressuspended in 3 
mL of drug-free media to wash out the drug from the cells. Using 200 µL of the ressuspended cells, 
a 10 fold serial dilution was performed and 5 µL of all dilutions were spotted in squared shaped 
7H10 plates in duplicate and incubated at 37 °C for 3 days. This plates are addressed as output 
CFU.
After the 3 days of incubation, colonies were counted  and duplicates averaged. To address 
the amount of killing the ratio output CFU over input CFU was calculated and  the 3 biological 
replicates averaged.
Figure 13: Overall procedure to perform a antibiotic killing assay using 15 ml conical tubes.
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3.6.4. OXIDATIVE STRESS GROWTH CURVE
Cells were thawed from -80 °C and grown for a day in 7H9 liquid media containing ADS 
supplement and 20 μg/mL Kanamicin. Cultures were then centrifuged at 4000 rpm for 5 minutes at 
room temperature and the supernatant discarded twice to wash off the drug and cells were grown in 
7H9+ADS overnight until they reach late log OD600 (around 0.6 - 1).
The next morning cultures were diluted to OD600 0.15 and cultured in biological triplicates 
with 0 and 3.2 mM H2O2. OD600 measurements were taken every 3 h for the first 9 h and at 29 or 30 
h.
Figure 14: Overview of an Oxidative stress growth curve experiment.
3.7. RNASE J OVEREXPRESSION STRAIN EXPRESSION LIBRARY 
PREPARATION
Using the 7H9 media, WT+E and WT+J strains were thawed from the -80 °C frozen stock 
and cultured for 1 day with 20 µg/mL Kananicin. On the next day cells were centrifuged 2 times at 
4000 rpm for 5 minutes and ressuspended in 5 mL drug free media and diluted to grown overnight 
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in triplicate at 37 °C until reach OD of approximate 0.8.
After total RNA extraction of the samples as previously stated on section 3.3.2., an RNA 
clean up procedure were performed in the cells followed by a DNase treatment and another RNA 
clean up (complete procedure is shown in sections 3.3.3. and 3.3.4. 
For the libraries construction only 2 of the 3 replicates of each strain was used. The samples 
used for this assay can be seen on the following table:
Table 7: RNase J strains samples used for library construction
Condition Replicates
WT+E 1 and 2
WT+J 1 and 2
JKO+J 1 and 2
3.7.1. rRNA REMOVAL
For this procedure the non-magnetic Ribo-ZeroTM rRNA Removal Kit for gram-positive 
bacteria from Epicentre was used following the manufacture recommendations with some minor 
modifications as stated in the sequence:
The microspheres were allowed to to equilibrate to room temperature and then mixed by 
vortexing for 20 seconds. 65 µL of microspheres were transferred into a clean 2 mL wash tube and 
centrifuged at 15000 rpm for 3 minutes at room temperature and the supernatant discarded. The 
microspheres were then washed with 130 µL of wash solution and mixed by vortexing to 
ressuspend the spheres. Tubes were centrifuged again at 15000 rpm for 3 minutes at room 
temperature and the supernatant discarded.
65 µL of Ressuspension solution was added and the spheres were ressuspended by 
vortexing. 1 µL of RiboGuard RNase Inhibitor was added to each tube and the tubes were stored at 
room temperature until use.
Meanwhile, the RNA samples were treated by adding in a 0.2 mL tube 4 µL Ribo-zero 
reaction buffer, 5 µg total RNA sample,  9 µL Ribo-zero rRNA removal solution and RNase-free 
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water to complete 40 µL. Samples were incubated in a thermocycler at 68 °C for 10 minutes and at 
room temperature for 15 minutes.
The RNA samples were then added to the ressupended microspheres solution and mixed by 
pipetting at least 15 times and vortexing at medium speed. The tubes were then incubated at room 
temperature for 10 minutes with vortex mixing for 5 seconds every 3 to 4 minutes. After the 
incubation period was over the samples were mixed by vortexing for 5 seconds and placed on a heat 
block at 50 °C for 10 minutes. The RNA-microspheres solutions were transferred to a microsphere 
removal unit and centrifuged at 15000 rpm for 1 minute at room temperature. The eluate containing 
the rRNA depleted samples was then purificated using a ethanol precipitation protocol as shown.
Samples had their volumes adjusted to 180 µL with RNase-free water and 18 µL of 3 M 
sodium acetate and 2 µL of glycogen (10 mg/mL) were added to each sample and  mixed by 
vortexing. Following, 600 µL ice-cold 100% ethanol was added to each sample and mixed gently 
and the samples were placed in -20 °C for at least 1 hour.
After the 1 hour incubation samples were centrifuged at 15000 rpm for 30 minutes at 4 °C 
and the supernatant was discarded. The pellet was washed twice with ice-cold 70% ethanol and 
centrifuged at 15000 rpm at 4 °C for 5 minutes. After carefully remove the supernatant of the 
second wash, samples were centrifuged for extra 30 seconds to collect any residual ethanol and any 
remaining supernatant was discarded. The samples were allowed to stay at room temperature for 5 
minutes and the pellet was dissolved in 20 µL RNase-free water. If not used immediately, samples 
were stored in -80 °C.
2 µL of each rRNA depleted sample were sent to Bioanalyzer analysis to address the quality 
and the rRNA content of the samples.
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3.7.2. RNA FRAGMENTATION AND cDNA SYNTHESIS
The library construction for these samples as described in this section and in section 3.7.3. 
and 3.7.4. were performed using the NEXTflexTM Rapid Directional qRNA-SeqTM Kit from Bioo 
Scientific Corp. with some modifications as following:
4 µL from each of the rRNA samples were combined with 10 µL RNase-free water and 5 µL 
NEXTFlex RNA fragmentation buffer and mixed thoroughly by pipetting. Samples were then 
incubated at 85 °C for 6 minutes to fragment the RNA and then placed in a ice-water bath to stop 
the reaction.
For the first cDNA strand synthesis 1 µL NEXTFlex first strand synthesis primer was added 
to the fragmented RNA and incubated for 5 minutes at 65 °C. After the tubes were placed in a ice-
water bath to stop the reaction, 4 µL NEXTFlex directional first strand buffer mix and 1 µL 
NEXTFlex rapid reverse transcriptase was added to each sample and after mixed by pipetting, 
samples were incubated for 10 minute at 25 °C followed by 50 minutes at 50 °C and 15 minutes at 
70 °C.
For the second cDNA strand synthesis 25 µL NEXTFlex directional second strand synthesis 
mix were added to each samples and after mixed by pipetting samples were incubated for 1 hour at 
16 °C.
The samples were then purified using the Agencourt AMPure XP Magnetic Beads following 
the guidelines as stated in the sequence: the magnetic AMPure Beads were allowed to equilibrate to 
room temperature and 90 µL beads were mixed to each cDNA (50 µL) sample by pipeting. Each 
sample were then transferred to a clean microcentrifuge tube and incubated for 5 minutes at room 
temperature. Tubes were then places in a magnetic stand and incubated for at least 5 minutes until 
the liquid became clear and the supernatant was discarded. With the tubes still on the magnetic 
stand, beads were washed 2 times with 200 µL 80% ethanol for 30 seconds and the supernatant was 
discarded. Tubes were removed from stand and allowed to air dry with the caps opened for 2 
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minutes.  Beads were removed from the magnetic stand and ressuspended in 17  µL RNase-free 
water by pipetting. After incubate the tubes at room temperature for another 2 minutes, tubes were 
placed again in the magnetic stand for 5 minutes. 16 µL of the clean supernatant were transferred to 
clean tubes stored at -20 °C until use.
3.7.3. ADENYLATION AND ADAPTER LIGATION
16 µL of each of the purified second strand synthesis product were mixed with 4.5 µL 
NEXTFlex Adenylation mix by thoroughly pipetting and incubated at 37 °C for 30 minutes 
followed by 5 minutes at 70 °C. Samples were then placed on ice and had 27.5 µL NEXTFlex 
ligation mix and 2 µL NEXTFlex directional qRNA molecular labels added to each sample. 
Samples were then mixed by pipetting and incubated for 10 minutes at 30 °C to perform the adapter 
ligation to the samples. After the incubation period, samples were purified twice using the 
Agencourt AMPure XP Magnetic Bead method.
The magnetic AMPure Beads were allowed to equilibrate to room temperature and 40 µL 
beads were mixed to each cDNA (50 µL) sample by pipeting. Each sample were then transferred to 
a clean microcentrifuge tube and incubated for 5 minutes at room temperature. Tubes were then 
places in a magnetic stand and incubated for at least 5 minutes until the liquid became clear and the 
supernatant was discarded. With the tubes still on the magnetic stand, beads were washed 2 times 
with 200 µL of 80% ethanol for 30 seconds and the supernatant was discarded. Tubes were removed 
from stand and allowed to air dry with the caps opened for 2 minutes. Beads were removed from the 
magnetic stand and ressuspended in 51 µL RNase-free water by pipetting. After incubate the tubes 
at room temperature for another 2 minutes, tubes were placed again in the magnetic stand for 5 
minutes and 50 µL of the clean supernatant were transferred to clean tubes.
The second purification step was then repeated the same way as stated above and the 
samples were eluted in a final volume of 34 µL of RNase-free water to recover 33 µL in the last 
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step. Samples were stored in -20 until use.
3.7.4. PCR AMPLIFICATION
For each sample from section 3.7.3., 1 µL NEXTFlex Uracil DNA glycosylase was added 
and samples were incubated at 37 °C for 30 minutes followed by an incubation at 98 °C for 2 
minutes. Samples were then transferred to ice to stop the reaction and 12 µL NEXTFlex PCR 
master mix, 2 µL NEXTFlex qRNA-Seq Universal forward primer and  2 µL NEXTFlex Index 
reverse primer were added to each tube. Samples WT+E 1 and WT+J 1 were mixed by pipetting 
then incubated in a thermocycler using the stated conditions: 98 °C for 2 minutes followed by 12 
cycles with 98 °C for 30 seconds, 65 °C for 30 seconds and 72 °C for 60 seconds and a final 
extension of 4 minutes at 72 °C. For samples WT+E 2 and WT+J 2 the same PCR reaction was 
performed but instead 12 cycles, it was used 16 cycles. Finally, samples were purified using the 
Agencourt AMPure XP Magnetic Bead method as showed in section 3.7.3. with the difference that 
the final samples were eluted in 17 µL of RNase-free water to recover 16 µL in the last step of the 
second purification. The libraries concentrations were measured using QuBit and they were stored 
in -20 °C until sent for sequencing. The following table shows which of the unique indexes used for 
each sample:
Table 8: Unique indexes used for WT+E, WT+J and JKO+J libraries 
Sample Unique index
WT+E rep 1 Primer Index 1 from kit
WT+J rep 1 Primer Index 2 from kit
JKO+J rep 1 Primer Index 4 from kit
WT+E rep 2 SSS 786
WT+J rep 2 SSS 787
JKO+J rep 2 SSS789
Since sample WT+J 1 had a low final concentration, 4 extras cycles were performed using 
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the following protocol: sample was concentrated using a speedvac to a final volume of 14.1 µL and 
then mixed by pipetting with 10 µL 5X GC Phusion Buffer, 2.5 µL 10 mM primer SSS 401, 2.5 µL 
10 mM primer SSS 402, 20 µL 5M Betaine, 0.5 µL Phusion polymerase and 0.4 µL dNTP mix (25 
mM each). The sample was then moved to a thermocycler using the following conditions: 98 °C for 
3 minutes, 4 cycles with 98 °C for 80 seconds, 60 °C for 30 seconds and 72 °C for 30 seconds and a 
final extension incubation at 72 °C for 5 minutes.
WT+J 1 sample was then purified using the Agencourt AMPure XP Magnetic Beads 
following the guidelines as stated in section 3.7.2. Finally, concentrations were measured using 
QuBit and sample was stored  in -20 °C until sent for sequencing. 
The following figure shows an overview of the library construction procedure:
Figure 15: Overview of WT+E and WT+J strains expression library construction. Modified from: ©Bioo 
Scientific Corp. NEXTflexTM Rapid Directional qRNA-SeqTM Kit Manual. 2014. V14.09
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3.8. DATA ANALYSIS FOR LIBRARIES
3.8.1. EXPRESSION LIBRARIES
After next generation sequencing using the Illumina® platform the reads were aligned back 
to M. smegmatis genome using the software Rockhopper (Tjaden, 2015;  McClure et al, 2013) 
available at: http://cs.wellesley.edu/~btjaden/Rockhopper/.
After alignment the conditions were the RPKM values were 0 were substituted by value 1 
and ratio between 2 different conditions was calculated. Finally the log2 RPKM ratios for each 
comparison were calculated and the genes were identified where the change was equal or greater 
than 2 fold (log2 values equal or greater than 1 for upregulated genes and log2 values equal or 
smaller than -1 for downregulated genes). In this list of genes the ones considered statistically 
differentially expressed were the ones with adjusted p-value below 0.05.
After the alignment several genes showed as "hypothetical proteins" so in order to find the 
function of those genes, their amino acid sequences were entered in BLAST (Altschul et al, 1990) 
and Phyre 2 (Kelley et al, 2015) software. This way most of the differentially expressed genes 
functions could be addressed.
Next, in order to find the pathways that were enriched under the tested conditions, the 
software DAVID (Huang et al, 2009) was used. 
3.8.2. 5' END MAPPING LIBRARIES
After the sequencing procedure the output for the samples was aligned with M. smegmatis 
genomes. After the alignment only the first nucleotide of each read 1 was analyzed for the libraries. 
Since there might be a little discrepancy between which is actually the true first nt of a particular 
transcript since RNA polymerase may not always start the transcription on the same exact 
nucleotide, normalizations are needed to get rid of the background. Samples were then run into a 
script to compare each site with its 10 coordinates upstream and downstream. This fist procedure 
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had the objective to get rid of the background and find the coverage ratio for each position. 
Following each coordinate were compared with the 4 sites upstream and downstream to find the one 
with the highest coverage. If this particular site is the one with the highest coverage it was 
considered the significant one, otherwise the adjacent positions were analyzed until the highest 
coverage value among the 9 coordinates (the 4 sites upstream, the site in question and the 4 sites 
downstream)  was found.
An arbitrary cutoff of 100 coverage on the converted libraries was used in order to get rid of 
the background. If a sample had coverage on the converted library lower than 100 for all 3 
conditions (no H2O2, H2O2 3h and H2O2 6h) it was excluded from the analysis. The cutoff chosen for 
this analysis is a little high due to the limitations of the library construction results as will be 
discussed in the results section.
Next, the log2 mean of the coverage of the 2 replicates from the converted libraries of one 
condition were plotted against each other  in order to find the differential 5' ends when comparing 
the 2 conditions in question. The differential 5' ends were considered the outliers of those graphs.
The coordinates found for the outliers were then analyzed using the software Artemis 
(Rutherford et al, 2000) and compared with the expression libraries in order to address if a specific 
coordinate was a transcription start site or a cleavage site.
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4. RESULTS FOR OXIDATIVE STRESS PROFILES
4.1. CULTURES FOR OXIDATIVE STRESS EXPERIMENTS
We  sought  to  identify  an  experimental  condition  in  which  M.  smegmatis experienced 
oxidative stress but was not killed. We therefore cultured a WT strain (Mycobacterium smegmatis 
strain mc2 155) with different concentrations of hydrogen peroxide to address how much stressor 
the bacteria is able to face and still continue growing.
Figure  16:  Oxidative  stress  growth for WT strain.  Triplicates  cultures  with  initial  OD600 0.15  were 
cultured at 37 °C with different concentrations of hydrogen peroxide (H2O2) and their growth was followed for 
9h. Error bars show standard deviation.
Figure 16 shows that different concentrations of hydrogen peroxide differentially impact the 
overall growth rate. While lower concentrations such as 0.2 and 0.4 mM have almost no apparent 
effect on cell growth, which were comparable to no exposure of H2O2, high concentrations such as 
6.4 or 12.8 mM showed no apparent  overall  growth although is  not clear  if  the cells  in  those 
cultures are dead. Li et al, 2015 reported that 7 mM hydrogen peroxide for 30 minutes was lethal to 
M. smegmatis, suggesting that, at least for the 12.8 mM concentration, cells are not viable.
Since 3.2 mM hydrogen peroxide impaired cell growth but did not halt it completely, we 
chose this concentration for preparation of samples for RNA-seq libraries construction.
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4.2. OXIDATIVE STRESS EXPRESSION LIBRARIES
To understand how mycobacteria is able to tolerate ROS, we decided to study M. smegmatis 
transcriptome under  oxidative  stress  by constructing  RNA-seq libraries. Cells were cultured in 
liquid media with 3.2 mM hydrogen peroxide or without hydrogen peroxide and harvested after 3 
and 6h to perform RNA extraction. Samples then had their rRNA depleted and the remaining 
mRNA was fragmented. Adapters were connected to both ends of the fragments and a PCR to 
enrich for fragments containing the full-length adapters was performed in order to provide enough 
sample for Illumina sequencing.
After sequencing, the software Rockhopper (Tjaden, 2015) was used to align reads to the M. 
smegmatis, normalize reads counts bewteen samples, and perform differential expression analysis. 
We then calculated  the log2 ratios of  RPKM values between pairs of conditions  to determine  the 
fold change between those specific conditions. After applying a cutoff of 2 fold expression 
difference between test sample and control sample and an adjusted p-value of 0.05 or less, lists of 
upregulated and downregulated genes were generated (tables 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 
19, 20).
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Table 9: Differentially expressed genes under oxidative stress conditions. DNA binding and repair. Numbers in 
italics are not significant.
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DNA binding and repair
Orthologs in TB Synonym Product
Rv0629c MSMEG_1325 exodeoxyribonuclease V subunit alpha RecD 1,58 1,27
Rv0630c MSMEG_1327 exodeoxyribonuclease V subunit beta RecB 1,64 1,08
Rv0631c MSMEG_1328 exodeoxyribonuclease V subunit gamma RecC 1,86 1,39
Rv3395c MSMEG_1620 Thought to be regulated by Rv2720|LEXA. 5,29 4,25
Rv3394c MSMEG_1622 DNA repair polymerase 5,33 4,06
Rv3370c MSMEG_1633 error-prone DNA polymerase DnaE2 5,13 3,94
Rv3297 MSMEG_1756 endonuclease VIII 2,87 2,12
Rv3202c MSMEG_1941 helicase, UvrD/Rep family protein 2,81 1,91
Rv3201c MSMEG_1943 ATP-dependent DNA helicase 2,12 1,17
Rv3062 MSMEG_2277 ATP-dependent DNA ligase LigB 1,51 1,19
MSMEG_2663 HNH endonuclease signature domain 3,94 2,58
Rv2737c MSMEG_2723 recombinase A RecA 2,45 1,59
MSMEG_2724 recombination regulator RecX 2,73 1,58
Rv2720 MSMEG_2740 LexA repressor 2,85 1,75
MSMEG_2742 DNA-damage-inducible protein 4,21 2,94
Rv2594c MSMEG_2943 Holliday junction resolvase RuvC 1,83 1,26
Rv2593c MSMEG_2944 Holliday junction DNA helicase RuvA 1,96 1,21
Rv2592c MSMEG_2945 Holliday junction DNA helicase RuvB 2,04 1,58
MSMEG_3164 DNA-binding protein -0,90 -1,11
MSMEG_3292 DNA-binding protein 2,22 1,58
Rv1765c / Rv2015 MSMEG_3404 HNH endonuclease domain-containing protein 2,63 2,18
Rv1633 MSMEG_3816 excinuclease ABC subunit B UrvB 2,10 1,64
MSMEG_3935 Possible integrase -1,25 -1,05
MSMEG_3957 HNH endonuclease 3,91 2,58
Rv2478c MSMEG_4701 single-stranded DNA-binding protein 1,00 1,58
Rv1277 MSMEG_5004 DNA repair exonuclease 2,30 1,79
Rv2100 MSMEG_5026 HNH endonuclease 4,75 3,58
Rv1210 MSMEG_5082 DNA-3-methyladenine glycosylase I (Tag) 1,89 1,23
Rv0336 / Rv051 MSMEG_5106 HNH endonuclease 3,46 2,32
MSMEG_5451 alkylated DNA repair protein 2,97 1,50
Rv2100/ Rv3776 MSMEG_5583 HNH endonuclease 5,39 4,80
MSMEG_5876 HNH endonuclease 3,05 1,72
MSMEG_5935 ATP-dependent DNA helicase 1,58 1,11
Rv1378c / Rv3074 MSMEG_6025 HNH endonuclease 6,17 5,13
Rv3585 MSMEG_6079 DNA repair protein RadA 1,54 1,30
Rv3129 MSMEG_6368 DNA-binding protein 1,49 0,64
MSMEG_6443 DNA polymerase IV DinP 3,46 2,32
MSMEG_6573 HNH endonuclease signature domain 4,95 3,46
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
Rv1128c / Rv1148c / 
Rv1702c
Table 10: Differentially expressed genes under oxidative stress conditions. Membrane proteins. Genes in italics 
are not significant.
Table 11: Differentially expressed genes under oxidative stress conditions. Detoxification. Genes in italics are not 
significant.
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Membrane proteins
Orthologs in TB Synonym Product
MSMEG_0185 MmpL6 protein 2,58 0,62
MSMEG_0520 porin -1,46 -1,14
Rv0309 MSMEG_0635 transpeptidase -1,74 -1,22
Rv0463 MSMEG_0904 membrane protein -1,02 -1,14
MSMEG_1266 ankyrin 2,17 2,58
Rv3482c MSMEG_1312 chromosome segregation ATPase 2,12 1,42
MSMEG_1315 MscS family protein -0,28 -1,01
MSMEG_1530 integral membrane protein 1,52 0,64
MSMEG_1680 major pilin protein fimA -0,81 -1,09
MSMEG_1777 UsfY protein -0,29 -1,12
MSMEG_1789 Possible membrane protein -0,63 -1,15
MSMEG_1791 UsfY protein -0,63 -1,25
MSMEG_1792 Possible membrane protein 0,08 -1,35
MSMEG_2004 arabinose-proton symporter -0,37 -1,48
MSMEG_2542 Membrane protein 3,58 2,81
MSMEG_2925 permease membrane component -0,50 -1,32
MSMEG_2946 transmembrane protein 1,58 0,79
MSMEG_3022 transglycosylase associated protein -0,44 -1,05
Rv1477 / Rv1478 MSMEG_3145 secreted cell wall-associated hydrolase -2,19 -0,55
MSMEG_3255 DoxX subfamily protein -0,86 -1,50
MSMEG_3439 putative membrane protein -0,79 -2,01
MSMEG_3541 cytochrome C biogenesis protein transmembrane region -0,35 -1,18
MSMEG_3593 sensor histidine kinase -0,14 -1,08
MSMEG_3815 drug efflux membrane protein 1,58 1,14
MSMEG_4030 membrane spanning protein 1,58 0,26
MSMEG_4536 TQXA domain-containing protein -1,42 -1,46
MSMEG_4689 LprJ -2,41 -0,41
MSMEG_5011 membrane protein 1,68 0,61
MSMEG_5051 major facilitator superfamily protein -1,45 -1,38
MSMEG_5187 tetracycline-resistance determinant TetV 1,48 1,15
Rv1069c MSMEG_5278 transmembrane protein -1,35 -1,17
MSMEG_5540 membrane protein -0,64 -1,58
MSMEG_5581 integral membrane protein 1,91 0,88
MSMEG_6006 membrane protein 2,27 1,12
MSMEG_6500 membrane protein -0,43 -1,50
MSMEG_6758 transport integral membrane protein -2,05 -1,17
MSMEG_6783 integral membrane protein 3,07 2,23
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
Detoxification
Orthologs in TB Synonym Product
Rv0187 MSMEG_0224 O-methyltransferase MdmC 1,26 0,77
MSMEG_0447 Peroxiredoxin 2,14 0,37
MSMEG_3560 glyoxalase -0,28 -1,21
MSMEG_5027 glyoxalase 2,17 1,81
MSMEG_5216 glyoxalase 3,16 2,54
Rv0887c MSMEG_5680 glyoxalase 2,54 1,95
Rv0801 MSMEG_5827 glyoxalase 1,57 0,76
MSMEG_6232 catalase KatA -0,35 -1,22
log2 H2O2 3h/no H2O2 log2 H2O2 6h/no H2O2
Table 12: Differentially expressed genes under oxidative stress conditions. Electron transport chain and some 
metabolism genes. Genes in italics are not significant.
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Electron transport chain
Orthologs in TB Synonym Product
MSMEG_0451 oxidoreductase -0,48 -1,28
MSMEG_0685 oxidoreductase, molybdopterin-binding subunit -0,66 -1,50
MSMEG_0686 oxidoreductase -0,26 -1,53
Rv3054c MSMEG_1016 NAD(P)H-dependent FMN reductase 2,81 2,05
MSMEG_1782 oxidoreductase, short chain dehydrogenase/reductase -0,35 -1,15
Rv3054c MSMEG_2296 NAD(P)H-dependent FMN reductase 2,81 2,05
MSMEG_2651 alkanesulfonate monooxygenase -1,64 -0,28
MSMEG_3137 oxidoreductase 1,83 0,93
MSMEG_4519 NrtC protein (oxidoreductase activity) -3,70 -2,70
MSMEG_5189 oxidoreductase -0,36 -1,30
MSMEG_6703 3,32 2,00
MSMEG_6747 oxidoreductase 2,06 1,32
MSMEG_6859 oxidoreductase 2,52 2,17
MSMEG_6884 NADP oxidoreductase 2,32 1,25
Metabolism
Rv2991 MSMEG_0048 pyridoxamine 5'-phosphate oxidase -1,03 -1,13
MSMEG_0147 C-5 sterol desaturase 0,00 -1,00
MSMEG_0208 ribonuclease -0,34 -1,29
MSMEG_0218 3-demethylubiquinone-9 3-methyltransferase 1,93 0,68
MSMEG_0239 O-acetylhomoserine/O-acetylserine sulfhydrylase -1,24 -1,08
Rv3714c MSMEG_0256 subunit of E3 ubiquitin ligase 2,55 1,36
MSMEG_0303 alcohol dehydrogenase 1,78 0,42
MSMEG_0338 acyl-CoA dehydrogenase -0,74 -1,08
MSMEG_0543 pyridine nucleotide-disulfide oxidoreductase 5,73 1,58
- MSMEG_0546 methyltransferase 2,70 2,17
MSMEG_0669 ADP-glucose pyrophosphorylase -0,32 -1,29
MSMEG_0670 FAD dependent oxidoreductase -0,29 -1,40
MSMEG_0684 aldehyde oxidase -0,41 -1,07
MSMEG_0773 acetyltransferase 2,68 1,77
Rv3714c MSMEG_0850 subunit of E3 ubiquitin ligase 2,91 1,32
Rv0068 Rv0439c MSMEG_0876 short chain dehydrogenase 1,22 -0,26
MSMEG_1026 acetyltransferase 1,87 1,42
MSMEG_1031 Ketosteroid isomerase-related protein 0,80 1,34
Rv0548c MSMEG_1075 naphthoate synthase -1,25 -1,17
MSMEG_1114 short chain dehydrogenase 2,08 1,70
MSMEG_1225 Possible aromatic acid decarboxylase 3,47 2,11
MSMEG_1236 Mpr protein 3,00 1,66
MSMEG_1269 Ser/Thr protein phosphatase 2,77 2,25
MSMEG_1272 ribosylglycohydrolase 2,42 2,58
MSMEG_1280 deacetylase 1,92 1,18
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
N5,N10- methylenetetrahydromethanopterin reductase-
related protein
Table 13: Differentially expressed genes under oxidative stress conditions. Metabolism genes part 2. Genes is 
italics are not significant.
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Metabolism
Orthologs in TB Synonym Product
Rv0751c MSMEG_1496 3-hydroxyisobutyrate dehydrogenase MmsB -1,83 -0,98
Rv0752c MSMEG_1497 acyl-CoA dehydrogenase -2,22 -1,37
Rv0753c MSMEG_1498 methylmalonate-semialdehyde dehydrogenase MmsA -2,03 -0,88
Rv0458 MSMEG_1543 eptc-inducible aldehyde dehydrogenase -1,82 -0,97
MSMEG_1546 -2,14 -0,24
MSMEG_1548 propanediol utilization: dehydratase, medium subunit -2,06 -0,64
MSMEG_1768 flavodoxin -0,36 -1,03
MSMEG_1771 methylase -0,60 -1,38
Rv3281 MSMEG_1812 acetyl-/propionyl-coenzyme A carboxylase AccE5 -0,58 -1,22
MSMEG_1916 lipoprotein -0,57 -1,70
MSMEG_1975 amidohydrolase 1,81 1,32
MSMEG_2079 alcohol dehydrogenase -0,90 -1,30
MSMEG_2177 fmnh2-utilizing oxygenase 2,22 1,87
MSMEG_2262 hydrogenase-2, small subunit HybA -1,84 -0,74
MSMEG_2264 peptidase M52, hydrogen uptake protein -1,26 -1,00
MSMEG_2306 acetyltransferase 1,87 1,42
MSMEG_2311 Ketosteroid isomerase-related protein 0,80 1,34
MSMEG_2346 phytoene synthase -0,39 -1,54
MSMEG_2347 phytoene dehydrogenase -0,62 -1,65
Rv2858c MSMEG_2597 aldehyde dehydrogenase -0,58 -1,00
MSMEG_2650 acyl-CoA dehydrogenase -2,81 -1,00
MSMEG_2791 pyridoxamine 5'-phosphate oxidase 1,97 1,05
MSMEG_2850 cell entry (mce) related family protein 1,49 0,95
MSMEG_2906 LLM class F420-dependent oxidoreductase 1,81 0,94
MSMEG_2920 aldo/keto reductase 1,58 1,00
Rv1493 MSMEG_3159 methylmalonyl-CoA mutase -1,86 -0,90
Rv1596 MSMEG_3201 nicotinate-nucleotide pyrophosphorylase 0,11 -1,08
MSMEG_3311 acyl carrier protein 0,07 -1,00
MSMEG_3325 carboxylate-amine ligase 1,11 1,32
MSMEG_3336 hydrolase 1,17 0,11
MSMEG_3384 isoflavone reductase 2,53 1,58
MSMEG_3385 ketosteroid isomerase 2,65 1,78
MSMEG_3418 polyketide cyclase -0,15 -1,06
MSMEG_3555 hydrolase 0,89 1,10
MSMEG_3583 monooxygenase 1,64 0,70
Rv3733c MSMEG_3679 phosphohydrolase 1,38 1,38
Rv1728c MSMEG_3714 glycoside hydrolase 0,53 1,58
MSMEG_3812 acyl-CoA thioesterase -0,92 -1,22
Rv2004c MSMEG_3942 Possible adenylate kinase -1,29 -1,17
MSMEG_3962 lactate 2-monooxygenase 1,58 0,26
MSMEG_4027 1,77 0,49
MSMEG_4031 Possible keratin associated protein 1,61 0,91
MSMEG_4032 zinc-binding alcohol dehydrogenase 2,75 2,61
MSMEG_4063 amidohydrolase 2,36 1,90
MSMEG_4064 zinc-binding alcohol dehydrogenase 3,12 2,93
Rv3463 MSMEG_4141 LLM class F420-dependent oxidoreductase 2,27 1,28
Rv2122c MSMEG_4181 phosphoribosyl-ATP pyrophosphatase -0,76 -1,36
MSMEG_4389 monooxygenase -2,22 -0,81
MSMEG_4399 Possible alpha-ketoglutarate decarboxylase 3,16 2,02
MSMEG_4465 cutinase 2,00 0,49
MSMEG_4538 cysteine desulfurase -2,00 -1,11
MSMEG_4618 isochorismatase -0,21 -2,04
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
coenzyme B12-dependent glycerol dehydrogenase 
small subunit
zinc-containing alcohol dehydrogenase superfamily 
protein
Table 14: Differentially expressed genes under oxidative stress conditions. Metabolism genes part 3. Genes in 
italics are not significant.
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Metabolism
Orthologs in TB Synonym Product
Rv2495c MSMEG_4710 branched-chain alpha-keto acid dehydrogenase subunit E2 -1,58 -1,00
Rv2500c MSMEG_4715 acyl-CoA dehydrogenase -1,58 -1,03
Rv2501c MSMEG_4716 acetyl-/propionyl-coenzyme A carboxylase subunit alpha -1,31 -1,24
Rv0974c Rv2502c MSMEG_4717 carboxyl transferase domain-containing protein -1,46 -1,17
MSMEG_4736 polysaccharide pyruvyl transferase 1,29 1,47
MSMEG_4737 polysaccharide pyruvyl transferase 1,38 1,57
MSMEG_4742 clavaldehyde dehydrogenase -1,32 -1,12
MSMEG_5002 hydrolase 1,87 1,22
Rv1140 MSMEG_5188 caax amino protease -0,23 -1,02
Rv3130c MSMEG_5242 acyltransferase -1,38 -1,09
Rv3129 MSMEG_5243 pyridoxamine 5'-phosphate oxidase -0,86 -1,26
Rv1070c MSMEG_5277 enoyl-CoA hydratase -1,35 -1,30
MSMEG_5343 acetyltransferase family protein -0,67 -1,46
MSMEG_5400 dehydrogenase -0,50 -1,44
MSMEG_5401 polyketide cyclase -0,36 -1,39
MSMEG_5404 propionate--CoA ligase -2,06 -0,94
MSMEG_5582 glucose-6-phosphate dehydrogenase 3,80 2,66
Rv0927c MSMEG_5584 short chain dehydrogenase 2,70 2,00
Rv0926c MSMEG_5586 diacylglycerol kinase 1,44 0,65
MSMEG_5590 carboxylate-amine ligase -0,15 -1,26
Rv0905 MSMEG_5639 enoyl-CoA hydratase -0,58 -1,04
Rv1482c / Rv3517 MSMEG_5643 subunit of E3 ubiquitin ligase 2,77 1,87
MSMEG_5732 monooxygenase 1,17 0,40
Rv2590 MSMEG_5739 long-chain fatty-acid--CoA ligase 2,20 1,38
MSMEG_5753 serine/threonine specific protein phosphatase 2,29 1,39
MSMEG_5799 nucleoside-diphosphate-sugar epimerase -0,21 -1,42
MSMEG_5826 pyruvate decarboxylase -0,77 -1,56
Rv0761c MSMEG_5866 alcohol dehydrogenase -1,41 -1,17
Rv1482c / Rv351 MSMEG_5917 subunit of E3 ubiquitin ligase 3,70 2,32
MSMEG_5956 NAD dependent epimerase/dehydratase 0,76 1,47
Rv3607c MSMEG_6102 dihydroneopterin aldolase -0,76 -1,02
Rv1254 MSMEG_6230 acyltransferase -0,38 -1,24
Rv3700c MSMEG_6246 pyridoxal-phosphate-dependent transferase 2,16 1,45
Rv3702c MSMEG_6248 class II glutamine amidotransferase 2,28 1,51
Rv3703c MSMEG_6249 iron(II)-dependent oxidoreductase EgtB 2,27 1,70
Rv3704c MSMEG_6250 glutamate--cysteine ligase 2,09 1,32
Rv3734c Rv3740c MSMEG_6322 -0,51 -1,32
Rv1758 MSMEG_6354 serine esterase, cutinase -0,56 -1,45
MSMEG_6454 LLM class F420-dependent oxidoreductase 1,51 0,90
MSMEG_6482 putative O-methyltransferase 0,00 -1,14
MSMEG_6512 acyl-CoA dehydrogenase -0,90 -1,39
MSMEG_6610 lipoprotein -0,17 -1,10
MSMEG_6616 S-(hydroxymethyl)glutathione dehydrogenase -0,54 -1,10
Rv1130 MSMEG_6645 2-methylcitrate dehydratase 4,39 3,32
MSMEG_6646 methylisocitrate lyase PrpB 3,74 2,42
Rv1131 MSMEG_6647 citrate synthase 3,74 2,06
Rv2967c MSMEG_6648 pyruvate carboxylase Pyc 3,17 1,81
MSMEG_6664 methylenetetrahydrofolate reductase -0,38 -1,04
Rv3696c MSMEG_6759 glycerol kinase -2,02 -1,19
Rv3302c MSMEG_6761 glycerol-3-phosphate dehydrogenase -1,68 -1,07
MSMEG_6768 halogenase -0,29 -1,06
MSMEG_6781 lipase 3,39 2,17
MSMEG_6858 epoxide hydrolase 1 2,49 1,93
MSMEG_6885 MmcI protein 1,77 1,26
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
bifunctional wax ester synthase/acyl-CoA diacylglycerol 
acyltransferase
Table 15: Differentially expressed genes under oxidative stress conditions. ATP, metal and RNA binding proteins; 
stress response and secreted proteins. Values in italics are not significant.
Table 16: Differentially expressed genes under oxidative stress conditions. Transcription regulators.
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Transcription regulator
Orthologs in TB Synonym Product
MSMEG_1303 transcriptional regulator 1,69 1,05
Rv0691c MSMEG_1420 -2,58 -1,26
MSMEG_1953 transcription factor WhiB 1,77 1,51
MSMEG_2125 glycerol operon regulatory protein -0,41 -1,44
MSMEG_2905 transcriptional regulator 1,83 0,76
MSMEG_3180 MerR family transcriptional regulator 0,63 1,35
MSMEG_3447 two-component system response regulator 2,79 2,08
MSMEG_4300 transcription regulator AmtR -0,17 -1,24
MSMEG_5186 HicB family protein 3,17 1,81
MSMEG_5542 transcriptional regulator -0,62 -1,44
MSMEG_6677 LysR family transcriptional regulator 1,38 1,38
MSMEG_0188 MarR family transcriptional regulator 1,18 -0,22
MSMEG_0268 GntR family transcriptional regulator -1,08 -1,26
MSMEG_0448 MarR family transcriptional regulator -0,82 -1,14
MSMEG_2017 MerR family transcriptional regulator -6,38 -0,52
Rv3744 MSMEG_5405 ArsR family transcriptional regulator 1,39 1,22
MSMEG_5731 GntR family transcriptional regulator 1,62 0,87
Rv0081 MSMEG_6451 ArsR family transcriptional regulator 1,00 3,58
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
mycofactocin system transcriptional 
regulator
Orthologs in TB Synonym Product
ATP binding
MSMEG_1013 ATP-binding protein 1,72 0,65
MSMEG_2293 ATP-binding protein 1,72 0,65
MSMEG_6612 ATPase, MoxR family protein -0,26 -1,14
Metal binding
MSMEG_0637 iron-sulfur binding oxidoreductase -0,34 -1,32
MSMEG_1976 metal-sulfur cluster biosynthetic enzyme 1,00 1,49
MSMEG_2415 hemerythrin HHE cation binding protein -0,44 -1,32
Rv2578c MSMEG_2990 Fe-S protein, radical SAM family protein 5,19 3,58
Rv1909c MSMEG_3460 ferric uptake regulation protein 1,35 0,52
Rv1284 MSMEG_4985 carbonic anhydrase -1,14 -1,10
MSMEG_5936 hemophore-related protein -0,06 -1,17
Rv3677c MSMEG_6190 metallo-beta-lactamase -0,60 -1,46
RNA binding
Rv3296 MSMEG_1757 DEAD/DEAH box helicase 1,64 1,17
MSMEG_1790 Rho termination factor -0,67 -1,42
MSMEG_3170 RNA-binding protein -0,58 -1,18
MSMEG_6005 RNA polymerase subunit sigma-70 2,30 1,76
Stress response
MSMEG_1770 general stress protein CsbD 0,29 -1,58
MSMEG_3242 starvation-inducible DNA-binding protein 3,74 2,32
MSMEG_3582 ATP-dependent protease La (lon) 1,93 1,49
Rv2031c MSMEG_3932 heat shock protein hspX -1,70 -2,12
MSMEG_5733 universal stress protein family protein -0,91 -1,07
Secreted protein
MSMEG_5355 PPE family protein 1,95 2,13
MSMEG_6144 PE family protein -0,42 -1,22
log2  H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
Table 17: Differentially expressed genes under oxidative stress conditions. Sigma factors and transporters 
proteins. Values in italics are not significant.
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Sigma factor
Orthologs in TB Synonym Product
Rv0182c MSMEG_0219 RNA polymerase factor sigma-70 1,72 0,91
Rv3223c MSMEG_0573 ECF sigma factor RpoE1 1,58 -0,26
Rv3223c MSMEG_0574 ECF sigma factor RpoE1 1,58 1,58
MSMEG_1418 RNA polymerase ECF-type sigma factor -1,32 1,58
Transporter proteins
MSMEG_0113 taurine transporter permease TauC -2,17 -1,26
MSMEG_0116 taurine import ATP-binding protein TauB -1,83 -0,70
MSMEG_0549 ABC transporter permease -0,67 -1,00
MSMEG_0551 nitrate/sulfonate/bicarbonate ABC transporter ATPase -1,58 -1,37
MSMEG_1169 integral membrane transporter 1,77 1,00
Rv0821c Rv3301c MSMEG_1605 phosphate transporter regulatory protein PhoU -0,37 -1,34
MSMEG_1683 cytosine/purines uracil thiamine allantoin permease -0,72 -1,01
Rv1859 MSMEG_2014 molybdenum import ATP-binding protein ModC -3,70 -0,38
Rv1858 MSMEG_2015 molybdate ABC transporter permease ModB -4,91 -0,20
Rv1857 MSMEG_2016 -6,13 -0,64
MSMEG_2680 amino acid transporter 1,58 0,49
MSMEG_2796 C4-dicarboxylate ABC transporter 3,25 1,00
MSMEG_2924 permease binding-protein component -0,31 -1,40
MSMEG_2926 -0,32 -1,15
MSMEG_2927 ABC transporter permease -0,48 -1,06
MSMEG_3314 transporter -0,14 -1,46
MSMEG_3386 shikimate transporter 2,04 1,17
MSMEG_3536 sugar transporter 0,06 -1,66
MSMEG_4318 Formate/nitrite family of transporters-like protein -0,93 -1,13
MSMEG_4355 peptide ABC transporter permease -1,12 -1,32
MSMEG_4385 peptide ABC transporter -2,12 -0,70
Rv1244 MSMEG_5054 ABC transporter substrate-binding protein -0,87 -1,22
MSMEG_5102 ABC transporter ATP-binding protein 1,81 2,17
MSMEG_5559 metabolite/sugar transporter 0,18 -1,36
MSMEG_6307 glutamine transporter permease -1,66 -1,04
MSMEG_6309 ABC transporter ATP-binding protein -1,37 -1,47
MSMEG_6544 transporter -0,57 -1,29
MSMEG_6769 -0,42 -1,16
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
molybdate ABC transporter periplasmic molybdate-binding 
protein ModA
glycine betaine/carnitine/choline transport ATP-binding 
protein opuCA
transporter monovalent cation:proton antiporter-2 (CPA2) 
family protein
Table 18: Differentially expressed genes under oxidative stress conditions. Protein regulation and tRNA. Values 
in italics are not significant.
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Protein regulation and tRNA
Orthologs in TB Synonym Product
MSMEG_3755 5S ribosomal RNA rrfA -0,24 -3,93
MSMEG_4929 5S ribosomal RNA rrfB -0,37 -4,03
MSMEG_5489 50S ribosomal protein L32 0,04 -1,87
Rv0881 MSMEG_5687 23s ribosomal RNA methyltransferase -0,58 -1,00
Rv2057c MSMEG_6067 50S ribosomal protein L33 0,42 1,22
MSMEG_6068 50S ribosomal protein L28 0,65 1,39
Rv3701c MSMEG_6247 histidine-tRNA ligase 1,81 1,00
MSMEG_6615 dithiol-disulfide isomerase -0,59 -1,09
MSMEG_0008 Ile tRNA -1,08 -2,83
MSMEG_0037 Leu tRNA -0,19 -4,97
MSMEG_0677 Gly tRNA -0,42 -1,06
MSMEG_1166 Tyr tRNA -0,19 -2,86
MSMEG_1337 Thr tRNA -0,31 -2,95
MSMEG_1965 Met tRNA 0,05 -2,71
MSMEG_2138 Ala tRNA 0,76 -3,19
MSMEG_2384 Gln tRNA 0,16 -2,73
MSMEG_2385 Glu tRNA 0,27 -3,28
MSMEG_2833 Val tRNA -0,51 -1,91
MSMEG_2836 Val tRNA -0,38 -3,23
MSMEG_3734 Pro tRNA -1,17 -1,00
MSMEG_4201 Leu tRNA 0,32 -2,65
MSMEG_4478 Asn tRNA -0,64 -3,36
MSMEG_4725 His tRNA -0,51 -1,54
MSMEG_4746 Lys tRNA 1,13 -2,46
MSMEG_5598 Arg tRNA -0,25 -3,83
MSMEG_5756 Asp tRNA -0,62 -2,40
MSMEG_5758 Lys tRNA -0,48 -4,98
MSMEG_6152 Thr tRNA -0,41 -3,33
MSMEG_6204 Pro tRNA 0,10 -3,86
MSMEG_6287 Ser tRNA -0,44 -2,23
MSMEG_6326 Ser tRNA 0,07 -5,43
MSMEG_6350 Ser tRNA -0,46 -2,15
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
Table  19: Differentially expressed genes under oxidative stress conditions. Proteins with unknown function. 
Values in italics are not significant.
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Unknown function
Orthologs in TB Synonym Product
MSMEG_0183 hypothetical protein 2,63 0,93
Rv0184 MSMEG_0222 hypothetical protein 1,13 0,39
Rv0185 MSMEG_0223 hypothetical protein 1,58 1,00
MSMEG_0493 hypothetical protein 2,97 2,26
MSMEG_0494 hypothetical protein 3,46 2,00
MSMEG_0558 hypothetical protein 0,47 1,28
MSMEG_0757 hypothetical protein 1,91 1,54
MSMEG_0910 hypothetical protein 2,58 3,58
MSMEG_0963 hypothetical protein 0,21 -1,42
MSMEG_1223 hypothetical protein 2,00 1,14
MSMEG_1237 hypothetical protein 3,75 3,38
MSMEG_1271 hypothetical protein 3,25 2,32
MSMEG_1273 hypothetical protein 2,91 2,75
MSMEG_1279 hypothetical protein 1,98 1,16
MSMEG_1282 hypothetical protein 1,96 1,14
MSMEG_1619 hypothetical protein 4,15 3,09
MSMEG_1627 hypothetical protein -1,15 -2,21
MSMEG_1766 hypothetical protein -0,58 -1,56
MSMEG_1781 hypothetical protein -0,54 -2,17
MSMEG_1783 hypothetical protein -0,51 -1,30
MSMEG_1788 hypothetical protein -0,53 -1,13
MSMEG_2115 hypothetical protein -0,89 -1,27
MSMEG_2199 hypothetical protein -0,65 -1,11
MSMEG_2258 hypothetical protein -1,32 -1,00
MSMEG_2261 hypothetical protein -2,04 -0,55
MSMEG_2376 hypothetical protein -0,39 -1,12
MSMEG_2679 hypothetical protein 1,40 1,21
MSMEG_2958 hypothetical protein -1,00 -2,58
MSMEG_3295 hypothetical protein 3,00 3,70
MSMEG_3352 hypothetical protein 1,46 0,81
MSMEG_3443 hypothetical protein -0,40 -1,02
MSMEG_3537 hypothetical protein 0,13 -1,12
MSMEG_3680 hypothetical protein 2,19 1,85
MSMEG_3713 hypothetical protein 1,95 2,85
MSMEG_4026 hypothetical protein 1,67 -0,30
MSMEG_4028 hypothetical protein 1,87 0,87
Rv2137c MSMEG_4195 hypothetical protein -0,28 -1,44
MSMEG_4257 hypothetical protein 1,99 1,36
Rv2342 MSMEG_4479 hypothetical protein -0,82 -1,55
MSMEG_4499 hypothetical protein 2,57 1,59
MSMEG_4500 hypothetical protein 2,58 0,00
MSMEG_4518 hypothetical protein -3,22 -3,49
MSMEG_4749 hypothetical protein 1,81 1,58
MSMEG_4961 hypothetical protein 2,20 0,75
MSMEG_4993 hypothetical protein -0,22 -1,62
MSMEG_5157 hypothetical protein 1,54 1,13
MSMEG_5406 hypothetical protein -0,84 -1,95
MSMEG_5461 hypothetical protein -2,54 -0,27
MSMEG_5543 hypothetical protein 0,42 -1,10
MSMEG_5558 hypothetical protein 2,67 1,45
MSMEG_5803 hypothetical protein -0,65 -1,00
MSMEG_5875 hypothetical protein -0,86 -1,24
MSMEG_6211 hypothetical protein -0,31 -1,58
MSMEG_6355 hypothetical protein -0,49 -1,08
MSMEG_6456 hypothetical protein 0,02 -1,43
MSMEG_6498 hypothetical protein 2,56 1,30
MSMEG_6501 hypothetical protein -0,03 -1,28
MSMEG_6566 hypothetical protein 2,17 1,06
MSMEG_6609 hypothetical protein -0,47 -1,41
log2 H2O2 3h/no H2O2 log2 H2O2 6h/noH2O2
Table 20: Differentially expressed genes under oxidative stress conditions. Proteins with undeterminated function 
and antigen and cell division. Values in italics are not significant.
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Undeterminated function
Orthologs in TB Synonym Product
MSMEG_0114 extracellular solute-binding protein 1,17 -1,00
MSMEG_0186 MmpS2 protein 2,77 1,30
MSMEG_0550 sulfonate binding protein -0,98 -1,33
Rv0288 Rv3017c Rv3019c MSMEG_0621 low molecular weight protein antigen 7 -0,65 -1,00
MSMEG_0696 alanine-rich protein -0,38 -1,44
MSMEG_1193 TROVE domain-containing protein 2,20 2,20
MSMEG_1251 gp58 [Mycobacterium phage Spartacus] 2,00 1,64
MSMEG_1264 prophage Lp1 protein 5 3,32 2,47
MSMEG_1270 gp75 [Mycobacterium phage Marvin] 3,30 3,51
MSMEG_1281 putative cytosolic protein 1,98 1,32
MSMEG_1356 DinB superfamily protein 1,96 1,51
MSMEG_1357 Azi37 / DinB superfamily protein 3,58 2,81
MSMEG_1384 cupin -0,81 -2,22
MSMEG_1421 mycofactocin precursor -1,29 -1,95
Rv0692 MSMEG_1422 mycofactocin system protein MftB -1,40 -1,33
MSMEG_1544 PduO protein -2,12 -0,12
MSMEG_1755 Anti-sigma factor, ChrR 1,96 0,97
MSMEG_1921 SecC motif-containing protein -0,47 -1,00
Rv1754c MSMEG_2107 conserved secreted protein -1,78 -0,83
MSMEG_3289 gp61 protein 0,10 -1,02
MSMEG_3298 response regulator receiver domain-containing protein 1,69 2,15
MSMEG_3377 gp15 protein 1,62 1,93
Rv2207 MSMEG_4275 phosphoribosyltransferase -0,65 -1,02
MSMEG_5502 ATPase AAA -1,81 -1,25
MSMEG_5761 cupin 0,79 1,75
MSMEG_6243 response regulator receiver domain-containing protein -0,86 -1,00
MSMEG_6359 trypsin domain-containing protein -0,24 -1,06
Antigen and Cell division
Rv1677 Rv2878c MSMEG_3543 Soluble secreted antigen MPT53 -0,42 -1,50
Rv1209 MSMEG_5083 cell division protein DivIVA 1,94 1,80
log2 H2O2 
3h/no H2O2
log2 H2O2 
6h/no H2O2
Among the upregulated genes, there was substantial  overlap between the two time points 
while the overlap between the downregulated genes was  quite small (figure 17). It is also worth 
noting that for the 3h condition, the majority of the differentially expressed genes (186 out of 217) 
were upregulated, while for the 6h samples the majority of the differentially expressed genes (201 
out of 298) were downregulated.
Previous  studies  on  yeast  have  shown that  H2O2 inhibits  translation  elongation  and can 
increase the time of ribosomal transit in mRNA by 50% in eucaryotes (Grant, 2011). The finding of 
some tRNAs on the downregulated list of genes for the 6h exposure to hydrogen peroxide is also 
consistent with the idea that translation is reduced. This may be also explained by the observation 
that oxidative stress induces reduction in protein production by inhibiting translation presumably to 
save energy for the essential processes in the cell and prevent synthesis of defective proteins (Grant, 
2011).
Figure 17: Overall analysis of number of genes up and downregulated under oxidative stress conditions 
and overlap between the 2 sets of genes.
The next  step was to  run DAVID analysis  (Huang  et  al,  2009)  in  order  to  identify the 
enriched pathways for the up and downregulated genes under oxidative stress conditions (table 13). 
As the table shows, DAVID (Huang et al, 2009) could not identify any statistically significant (0.05 
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or smaller value for the Bonferroni correction) clusters within the downregulated genes lists. For the 
upregulated gene lists on the other hand, both time-points showed enrichment in HNH nucleases, 
with  enrichment  scores  of  5.87  and  4.22  for  3h  and  6h  of  exposure  to  oxidative  stress.  The 
enrichment scores tell us which gene groups are more significant in the tested experiment and is 
measured by the software using the geometric mean of the p-values of the terms in a particular 
cluster followed by the application of the minus log of the mean (Huang et al., 2007). Therefore a 
high enrichment score suggests that this particular group of members is involved in more relevant 
roles (Huang et al., 2007). For the three hour time point, 168 genes of a total of 186 genes were 
included in the analysis,  and of those 168 genes,  11 were classified as  belonging to  the HNH 
nuclease cluster. For the six hour time-point, 88 genes out of a total of 97 genes were included in 
the analysis  and of those 88 genes,  5 genes were classified as belonging to the HNH nuclease 
cluster. DAVID was not able to include some if the genes in the analysis because some of then were 
not able able to be mapped to the database. Even using a custom background, the gene list had to be 
converted to DAVID format in order to run the software and, also for this step, not all genes were 
able to be mapped to M. smegmatis genome.
Table 21: DAVID result for the enrichment pathway analysis for both up and downregulated genes  
under 3h and 6h of hydrogen peroxide treatment. The table is only showing the statistically significant clusters  
when using a cutoff of 0.05 for the Bonferroni correction.
H2O2  3h / no H2O2 upregulated genes
Cluster name Enrichment score Bonferroni correction
HNH Nuclease 5.87 ≤ 0.036
H2O2 3h / no H2O2 downregulated genes
Cluster name Enrichment score Bonferroni correction
No statistically significant 
clusters found
H2O2 6h / no H2O2 upregulated genes
Cluster name Enrichment score Bonferroni correction
HNH Nuclease 4.22 ≤ 0.0098
H2O2 6h / no H2O2 downregulated genes
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Cluster name Enrichment score Bonferroni correction
No statistically significant 
clusters found
Having HNH nucleases enriched within the upregulated genes was an expected result as this 
enzyme domain is found in proteins shown to take part in many cellular processes, including DNA 
repair  and  recombination  (Pediaditakis  et  al,  2012).  Also,  HNH  nuclease  family  genes  were 
previously shown to to be induced in M. smegmatis in response to oxidative stress (Li et al, 2015) 
and, as stated before, oxidative stress may cause DNA damage (Dussurget and Smith, 1998) which 
explains why this class of proteins is upregulated in response to ROS.
A previous study (Li et al, 2015) exposed M. smegmatis early log phase cultures to 0.2 mM 
and 7 mM H2O2 for 30 minutes and then performed a RNA-seq experiment to try to understand 
mycobacterial response to oxidative stress under low and high concentrations of hydrogen peroxide. 
We constructed heat maps to compare the expression of differentially expressed genes identified in 
that study and in ours (Figure 18). 
Figure 18: Heat map showing the comparison between data from Li et al, 2015 and the data gathered in 
this project. The figure shows the log2 ratios of FPKM (Li et al, 2015) or log2 ratios of RPKM (data from this 
project) for the included genes when compared 2 different conditions. Genes were grouped by function according 
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to Li et al, 2015. Test samples are the ones containing hydrogen peroxide in the specific concentrations shown in 
the figure and control samples consists in samples were the cells were not exposed to hydrogen peroxide during 
the experiment. This figure only includes the genes found on  both data sets and the * indicates genes that 
differential expression (2 fold or higher difference) in at least one comparison in our data.  This heat map was 
constructed using the software GENE-E from Broad Institute available at: 
http://www.broadinstitute.org/cancer/software/GENE-E/index.html.
We saw that many of the sigma factors, transcription regulators and detoxification enzymes 
that were included in the Li  et al,  2015 study were also differentially expressed  3h or  6h after 
addition of 3.2 mM of hydrogen peroxide in our study.
As expected, DNA repair enzymes are upregulated for both data sets, with special attention 
to MSMEG_1622 and dnaE2, which were the most highly upregulated genes in our study. dnaE2 
(MSMEG_1633) encodes  a DNA polymerase III α chain which is known to be involved in DNA 
repair and emergence of RIF resistance in Mtb (Boshoff et al, 2003). MSMEG_1622 sequence was 
retrieved from Smegmalist website and analyzed using BLAST, which showed the gene is likely to 
encode a DNA repair polymerase that facilitate translesion synthesis.
When looking at the transcription factors, we noted that our data does not seem to have any 
strong differential expression. Li et al., 2015 data, on the other hand, present a trend of upregulated 
transcription factor, specially for the 7 mM condition. It is interesting to notice that in some cases, 
for example MSMEG_4517 and MSMEG_4925, we do see an opposite trend in the data, where our 
data for those particular genes shows downregulation and Li's group show upregulation.
4.3. OXIDATIVE STRESS 5' END MAPPING LIBRARIES
With the objective of exploring the RNA cleavage sites present in M. smegmatis to infer if 
changes in RNA cleavage contribute to the oxidative stress response, we constructed 5' end 
mapping libraries from the same RNA samples used for expression library construction above. After 
rRNA depletion, each sample were divided into two and one of then went through an 
polyphosphatase treatment while a mock treatment was performed with the other half. The 
polyphosphatase treatment degraded the triphosphate present in the 5' end of the transcription start 
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sites to monophosphate so the enzyme T4 RNA ligase could act in both transcription start sites and 
cleavage sites, that naturally have a monophosphate in their 5' end. On the mock treatment sample 
on the other hand, only the cleavage sites will have the adapters ligated once they were the only 
ones with a monophosphate in the 5' end. Next, an adapter was ligated to the 5' end monophosphate 
of all the available mRNA in the sample. RNA was fragmented, and cDNA was synthesized using a 
random primer linked to a 3' adapter sequence. PCR was performed to enrich for the fragments with 
both  adapters, and samples were sequenced using Illumina platform. The first nucleotide of each 
Read 1 corresponds to the precise 5' end of a transcript.
Reads were aligned to M. smegmatis genome and, after some normalization steps, the first 
nucleotide of each transcript (henceforth called "5' end coverage") was analyzed in order to (1) infer 
if that particular coordinate was a transcription start site or a cleavage site and (2) determine if 
abundance of each 5' end was affected by hydrogen peroxide.
Reads with 5' end coverage below an arbitrary cutoff of 100 normalized reads were filtered 
out to remove low-abundance 5' ends and limit further analysis to reproducible data. To address if 
the arbitrary cutoff for 5' end coverage of the converted libraries was appropriate  to eliminate the 
background from the samples, graphs showing the correlation between the 2 biological replicates 
used in this experiment are shown in figure 19. A appropriate  library should have little to no 
background and good correlation between the biological replicates of the same condition.
Figure 19: Comparison between replicate 1 and 2 for the control libraries with no hydrogen peroxide. 
The left panel shows the log2 values for 5' end coverage of the non-converted libraries when no H2O2 is present in 
the culture. The right panel shows the log2 values for coverage of the converted libraries when no H2O2 is present 
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in the culture. R2 values show how correlated the samples are with each other.
The graphs above show that the 100 cutoff of the converted libraries, although conservative, 
is good option due to the limitations of this data set. When analyzing the results without applying 
the arbitrary background, the biological replicates were less  well  correlated (figure 20), which 
makes difficult to compare conditions and to compare converted and non-converted libraries within 
each condition.
Figure 20: Comparison between replicate 1 and 2 for the control libraries with no hydrogen peroxide 
before applying the cutoff of 100 coverage for the converted libraries.
To assess our ability to distinguish transcription start sites from cleavage sites, the ratio of 
coverage  for  each  5'  ens  in  the  converted  library  relative  to  the  non-converted  library  was 
determined  and  the  distributions  of  the  log2 of  these  ratios  were  assess.  Log2 converted/non-
converted ratio distributions for the 2 no H2O2 replicates are shown (figure 22). We expected to see 
binomial distributions with cleavage sites equally represented in the two libraries and transcriptions 
start sites more highly represented in the converted library (figure 21). However, the distributions 
were not clearly binomial, indicating that our ability to distinguish between transcription start sites 
and cleavage sites is limited.
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Figure 21: Expected histogram plot for the 5' end mapping data showing a binomial distribution. 
Retrieved from Shell et al., unpublished data.
Figure 22: Histograms showing the number of 5' ends by log2 ratio of converted over non-converted 
coverages for the 2 replicates of the no H2O2 condition.
Next, we looked into the plots comparing the log2 ratio between the converted and non-
converted libraries for the 2 biological replicates from each condition (figure 23). The R2 for these 
graphs are below expected. R2 represent the correlation between the samples and while  it was 
expected that biological replicates would have some variability, values around 0.25 to 0.47 are low 
and limit our ability to distinguish transcription start sites from cleavage sites with high confidence. 
This further shows the limitations of the data set used.
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Figure 23: Plots of log2 ratios between the converted and non-converted libraries comparing the 2 
biological replicates for no H2O2, H2O2 3h and H2O2 6h. R2 values show the correlation between the 2 biological 
replicates.
The dephosphorylation for the converted libraries may not have worked as well as planned, 
so a way to increase this reaction efficiency would be to increase the incubation time from 1 hour to 
2 hours for example. In the case of the fragmentation, the samples appeared to be over fragmented, 
(figure 24) which lead to smaller fragments that could be easily washed away during the 
purification steps. Over-fragmentation may also lead to excess variability between replicates due to 
less available starting material for the enrichment PCR step, and therefore more PCR cycles are 
needed.  More  PCR cycles  leads  to  more  variability  between  samples  because  of  "jackpotting" 
(Shell,  personal  communication). So instead of using 94 °C for 11 minutes, for next libraries 
constructions could be a nice idea to decrease time and temperature for the fragmentation step.
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Figure 24: Results from Bioanalyzer using oxidative stress libraries samples. Samples were compared 
with a library from Mtb constructed by Professor Shell in an independent experiment. The no H2O2 replicate 1 
and 3.2 mM H2O2 3h replicate 1 libraries appear to have an smaller overall fragment distribuition size than the 
other samples, which suggests that those samples had their mRNA overfragmented. We can also notice a sharp 
peak around 150 bp for some of the samples, for example no H2O2 replicate 1 and 3.2 mM H2O2 3h replicate 2. 
This peak is possible adapter dimer that was not efficiently removed  from the samples by  the magnetic bead 
purification.
Even with some limitations as stated above, the highest and lowest ratios are  likely to 
represent transcription start sites and cleavage sites, respectively. In order to verify that prediction, 
sequence logos were created with Web Logos (Crooks et al, 2004) using the 500 highest log2 ratios 
between the converted and non-converted libraries and the 500 lowest log2 ratios between the 
converted and non-converted libraries for each condition (figures 25, 26, 27).
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Figure 25: Web logos for the predicted transcription start sites (500 highest ratios) and cleavages sites 
(500  lowest  ratios)  under no H2O2 conditions. Figures made using the website 
http://weblogo.berkeley.edu/logo.cgi
Figure 26: Web logos for the predicted transcription start sites (500 highest ratios) and cleavages sites 
(500 lowest ratios) under H2O2 3h conditions. Figures made using the website 
http://weblogo.berkeley.edu/logo.cgi
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Figure 27: Web logos for the predicted transcription start sites (500 highest ratios)  and cleavages sites 
(500 lowest ratios) under H2O2 6h conditions. Figures made using the website 
http://weblogo.berkeley.edu/logo.cgi
The sequence logos indicate that the highest 500 ratios in each condition are indeed enriched 
for transcription start sites, as we observed an adenine and thymine-rich region around the -10 site, 
which resembles a housekeeping sigma factor binding site from E. coli (Lodish et al, 2000) and M. 
tuberculosis (Shell et al, 2015). In M. tuberculosis, a purine at the position +1 is reported to be 
characteristic of transcription start sites (Shell et al, 2015), consistent with our data and supporting 
the idea  that the 500 highest ratios represent transcription start sites in M. smegmatis. For the 
predict cleavage site (500 lowest ratios) is possible to see that before the cleavage site every 3 
nucleotides  we usually  see either a cytosine or a guanine. This pattern is characteristic of 
mycobacterial coding sequences, where the last nt of the codon will be more likely to be a cytosine 
or guanine as a results of GC rich genomes (Scapoli et al, 2009). Also, as described and mapped in 
Mtb, most cleavage sites occurred immediately between cytosines (Shell et al, unpublished data), so 
observing enrichment for this residue suggests that the 500 lowest ratios are indeed cleavage sites.
In order to understand the basis of the gene expression differences observed in section 4.2., 
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where we discussed the results for the expression libraries we constructed, we wanted to identify 
both transcription starts sites and cleavage sites that were differentially abundant in oxidative stress. 
We therefore compared different conditions to see which were the differentially expressed 5' ends. 
This was done by plotting the mean of the log2 converted library coverages from the 2 replicates for 
one condition against the mean of the log2 converted library coverage from the 2 replicates for the 
other condition (figure 28).
Figure 28: Comparison between the biological replicates converted libraries under no H2O2   conditions 
with no H2O2 vs H2O2 3h, no H2O2 vs H2O2 6h and H2O2 3h vs H2O2 6h. For all plots only the converted libraries 
were used. log2_mean_con_cov strands for log2 mean of the coverage of the 2 replicates from the converted 
libraries.
Figure 28 shows in  panel  A  the comparison between the 2 replicates under no H2O2 
conditions. This plot serves as a "calibrator" to analyze the other plots as we expect no biological 
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meaningful differential 5' end abundance between the two biological replicates. Panel B shows the 
differential 5' ends when comparing no H2O2 with H2O2 3h conditions, the differential 5' ends are 
the outliers of the plot. The same is true for panel C which compares no H2O2 with H2O2 6h; again 
the outliers correspond to the differential 5' ends. Finally, panel D shows the comparison between 
H2O2 3h with H2O2 6h. This plot has fewer outliers, suggesting  that the number of differential 5' 
ends is minimal. In order to establish a meaningful cutoff for identifying differentially abundant 5' 
end we determined the log2 of the mean 5'end converted library coverage ratio between conditions, 
and calculated Z-scores for these ratios. A 5'end was considered to be differentially abundant  if it 
had a Z-score of at least 3, representing log2 ratios at least 3 standard deviations from the mean. 
Data analysis will continue be performed using the differentially abundant 5' ends to understand the 
mechanisms mycobacteria uses under oxidative stress conditions.
5. PHENOTYPIC ASSAYS FOR RNASE J
5.1 CONSTRUCTION  OF  RNASE J KNOCKOUT,  OVEREXPRESSION  AND 
COMPLEMENTED STRAINS.
In order to construct an RNAse J deletion strain, we used a recombineering strategy (Van 
Kessel and Hatfull, 2008)  as described in the methods section 3.5.1. A plasmid encoding phage 
recombinases behind an inducible promoter was transformed into the WT strain and induced prior 
to  transformation with a  cassette  to  replace the RNase J  coding sequence with the hygromicin 
resistance gene. In order to evaluate the effects of overexpression of RNase J, the RNase J coding 
sequence was cloned into plasmid PJEB402, which integrates in the L5 attB site (Lee et al., 1991), 
to create the plasmid pSS138. pSS138 was transformed into both the WT strain and the RNase J 
deletion  (JKO)  strain  to  create  overexpression  strain  and  complemented  strains,  respectively. 
pSS138  contains  a  synthetic  promoter  called  MOP,  which  stands  for  mycobacterial optimal 
promoter, and it is a strong promoter with constitutive expression (Fortune  et al, 2005). For this 
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complementation plasmid the synthetic promoter was preferred over the native promote as we were 
not able to identify with confidence the exact place in  M. smegmatis genome where the RNase J 
native promoter was.
Figure 29: Transformations performed during the course of this project to obtain the WT+E, WT+J, 
JKO+E, JKO+J  strains.
To validate our approach, the expression level of RNase J was assayed by qRT-PCR in the 
following strains: WT+E (WT strain transformed with "empty" plasmid pJEB402), WT+J (WT 
strain transformed with RNase J complementation plasmid pSS138), JKO+E (RNase J KO strain 
transformed with "empty" plasmid pJEB402) and JKO+J (RNase J KO strain transformed with 
plasmid pSS138). The RNase J expression relative to the housekeeping gene sigA was determined 
(Figure 30).
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Figure 30: RNase J expression level relative to the housekeeping gene sigA for strains WT+E, WT+J, 
JKO+E and JKO+J. Experiment was done in biological triplicates for each strain. Error bars show standard 
deviation.
We observed that the WT+J strain has 3.5 fold higher  RNase J expression than the WT+E 
strain. This was expected as  the WT+J strain contains 2 copies of the RNase J coding sequence. 
JKO+E on the other hand had no detectable expression of RNase J consistent with the successful 
deletion of the gene from the genome. The JKO+J strain showed about twice the expression level of 
the WT+E strain. For the KO complemented strain, we had no expectations regarding its expression 
level as we did not know beforehand how the MOP promoter would compare with the native 
promoter. These results suggests that MOP is a stronger promoter than the RNase J native promoter.
5.2. MINIMAL INHIBITORY CONCENTRATION
Once the set of 4 strains were constructed and validated for RNase J mRNA level, we 
decided to challenge them using the first line of defense against Mtb antibiotics, INH and RIF, to 
determinate if RNase J plays any role in drug tolerance. In order to do that, drug tolerance was 
measured by calculating the Minimal Inhibitory Concentration (MIC) which is defined as the lower 
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drug concentration where there is no color change in the resazurin dye.  Briefly, cells were grown 
with different concentrations of antibiotic for 48h, and after the first 24h a resazurin dye was added 
to determine  which cultures were still growing under the tested conditions. Unfortunately our 
results had substantial variability between isolates than was expected for the same genotype (Table 
22).
Table 22: Summary of MIC results for isoniazid (INH) and rifampicin (rif) for strains and isolates 
tested. JKO1 and JKO2 are  2 different RNase J isolates that were independently transformed with the empty 
vector and complementation vector. WT+E 4* is a strain originated from a different transformation than the 
other WT+E isolates used for this assay.
Strain MIC - INH 
(μg/mL)
Times 
measured
 MIC - RIF 
(μg/mL)
Times 
measured
WT 3 2 1.56 2
WT+E 1 6 2 3.125 2
WT+E 2 - - 1.56 / 3.125 2
WT+E 3 12 / 24 1 - -
WT+E 4* - - 1.56 1
WT+J 1 12 2 6.25 2
WT+J 2 6 1 3.125 / >3.125 2
WT+J 3 6 1 3.125 1
JKO1 6 2 <0.39 2
JKO1+E 1 6 2 <0.39 2
JKO1+E 2 - - 1.56 1
JKO2+E 1 3 1 0.78 1
JKO2+E 2 3 1 1.56 2
JKO2+E 3 - - 0.78 1
JKO2+E 4 - - 0.78 1
JKO1+J 1 24 2 0.78 2
JKO1+J 2 > 24 2 1.56 1
JKO2+J 1 12 2 3.125 1
JKO2+J 2 12 1 1.56 1
JKO2+J 3 - - 1.56 1
JKO2+J 4 - - 1.56 1
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Even there is no data for some  presented isolates, we  notice  there is some variability 
between isolates  of  the  same  strain. Isolate WT+E 3 shows extreme resistance  to INH when 
compared to other WT+E isolates, so we believe it is not representative of the real phenotype for 
this stain. Rather, it may have acquired a spurious mutation that confers INH resistance. The MIC 
values that more likely represent the real phenotype for WT+E is 6 μg/mL for INH and 1.56 μg/mL 
for RIF since they match more closely the untransformed WT strain. Taneja  and  Tyagi,  2007 
reported, using a similar assay, that the MIC for INH is 4  μg/mL for WT M. smegmatis mc2155 
strain, which is similar to the results obtained by our untransformed WT (3 μg/mL). For RIF, on the 
other hand, the reported MIC values are between  0.5 and 1 μg/mL (Taneja and Tyagi, 2007) which 
are a little lower than the 1.56 μg/mL but still can be considered similar.
When considering the WT+J strain, the INH MIC  is most likely 6 μg/mL which is 
comparable to the WT+E isolates, and the RIF phenotype is likely between 3.125 μg/mL and 6.25 
μg/mL. The WT+J strains appear to be slightly more resistant to RIF than WT+E, suggesting that 
having more RNase J in the cell gives the mycobacteria an advantage in the presence of RIF.
For the JKO isolates the MIC seems to be somewhere between 3 μg/mL and 6 μg/mL for 
INH and between 0.78 μg/mL and 1.56 μg/mL for RIF. Lack of RNase J therefore seems to have 
little impact on the ability of these bacteria to grow in the presence of INH and RIF, although there  
may be a subtle increase in sensitivity to RIF.
For the complementation strain isolates (JKO+J), the INH MIC appears to be between 12 
μg/mL and 24 μg/mL, while for the RIF MIC the value is more likely to be 1.56 μg/mL. When 
looking at the INH phenotype, the JKO+J  isolates show more tolerance to INH than WT+E and 
WT+J. Comparing these results with RNase J expression levels makes it difficult to draw any 
obvious conclusion, as  the strain with more RNase J transcript levels (WT+J) did not show the 
higher MIC value, while the strain with no detectable RNase J expression (JKO) had the lower MIC 
value.
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When looking at the RIF results, on the other hand, we see the WT phenotype restored in the 
JKO+J isolates. Is also possible to observe a trend in these results: more expression of RNase J will 
modestly increase tolerance to RIF stress, while no RNase J at all will modestly increase sensitivity 
to this particular drug. This trend correlates with RNase J relative expression values from section 
5.1.
5.3. ANTIBIOTIC KILLING ASSAYS
The MIC assays shown in the previous section are only able to address if bacteria are 
growing or not under the tested conditions and, in this case, a lack of growth does not necessarily 
mean death. Bacteria may persist  in  a  viable  but  non-growing  state, and resume growth when 
conditions improve. For this reason MIC assays are often complemented with a killing assay.
The following figure shows the results for the INH killing assay comparing strains with the 
empty vector and without the empty vector.
Figure 31: INH 24 μg/mL killing assay to  compare  strains  containing  the  empty  vector  (WT+E1, 
WT+E2, JKO1+E1 and JKO1+E2) and without the empty vector (WT and JKO1). Survival rate is calculated by 
dividing CFU on drug-free plates after 24h of exposure to drug in liquid media by input CFU. Error bars show 
one standard deviation.
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Figure 31  shows that there is an apparent difference between survival of WT and JKO1, 
where JKO1 strain seems able to survive better when challenged with INH. It also shows that while 
transforming the empty vector in the WT strain appeared to have no effect on survival, it did affect 
the survival when transforming the RNase J KO strain (JKO1) as JKO1+E1 looks different from 
JKO1 although is unclear if JKO1+E2 is different from JKO1. It is worth noticing that JKO1+E1 
and JKO1+E2 are colonies derived from the same transformation plate and they both came from the 
JKO1 strain.
JKO1+E1 presents an extreme phenotype when challenged with 24 μg/mL INH, where it is 
actually able to grow while the other strains are killied. Since this is not seen in the other RNase J 
KO strains, it suggests that for this particular isolate some other mutation may have happened when 
the transformation was performed.
This graph also suggests the existence of variability between strains originated from the 
same common ancestor. For this reason, we  decided to test the other available isolates from the 
initial RNase J KO transformation plate using the same drug concentration of 24 μg/mL INH 
(figures 32, 33, 34).
Figure 32: INH 24 μg/mL killing assay using isolates JKO1 to JKO4. Survival rate is calculated by 
dividing output CFU by input CFU. Error bars show one standard deviation.
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Figure 33: INH 24 μg/mL killing assay using isolates JKO5 to JKO8. Survival rate is calculated by 
dividing output CFU by input CFU. Error bars show standard deviation.
Figure 34: INH 24 μg/mL killing assay using isolates JKO9 to JKO12. Survival rate is calculated by 
dividing output CFU by input CFU. Error bars show one standard deviation.
The 3 figures above show the phenotypes for colonies JKO1 to JKO12 in order to address 
the RNase J KO resistance to INH. For colonies JKO1 and JKO4 we observed less killing of the 
bacteria than for the WT colonies. On the other hand, colonies JKO2, JKO3, JKO5, JKO6, JKO7, 
JKO8, JKO9, JKO10, JKO11 and JKO12 did not seem to have any difference when compared to 
WT colonies. This leads us to conclude that the effect on RNase J KO survival under INH induced 
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stress conditions is not large enough, if any, to be detected by this assay.
5.4. OXIDATIVE STRESS GROWTH CURVE
In order to test if RNase J has a role in oxidative stress tolerance in mycobacteria, cells were 
grown in liquid media with 3.2 mM H2O2 for around 30 hours (figure 35). 
Figure 35: Graph showing the phenotype of some isolates of the RNase J related strains when challenged 
with H2O2. Error bars are one standard deviation.
The graph shows that the strains WT+E2, WT+E5 and JKO1+E2 are able to grow when 3.2 
mM H2O2 was added to the media at time zero. JKO+E2 is also shown to have an overall slower 
growth when compared with the WT+E2 and WT+E5 strains in the presence of 3.2 mM H2O2. On 
the other hand, strains WT+J3 and JKO1+J2 did not show any growth after 30 h of culture. We 
were surprised  that the JKO+J2 strain did not grow, as we had expected it would have a similar 
phenotype to WT+E. This result suggests that excess of RNase J transcript, as shown is section 5.1 
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that WT+J and JKO+J have more relative expression of RNase J than WT+E, confers a 
disadvantage when facing oxidative stress conditions.
5.5. EXPRESSION LIBRARIES FOR RNASE J OVEREXPRESSION AND 
COMPLEMENTATION STRAINS
Expression libraries were constructed using the 4 sets of strains (WT+E1, WT+J1, JKO1+E1 
and JKO1+J1) to address how RNase J could change the cell transcriptome. Briefly, RNA was 
extracted from late log phase cultures and rRNA was depleted. After fragmentation of the RNA, the 
transcripts were used as template for cDNA synthesis and adapters were attached to both ends of the 
cDNA fragments by PCR reactions. Given the fact that the JKO1+E1 isolate had drug assay 
phenotypes that were not seen in other JKO isolates, we suspect that this particular isolate has an 
additional mutation. For this reason the results obtained for this strain expression library will not be 
discussed in this section.
Results obtained from the Bioanalyzer (Figure 33) for the rRNA depleted samples for strains 
WT+E, WT+J and JKO+J indicate that the WT+E1 profile is quite different from WT+E2 and the 
WT+J and JKO+J isolates, showing a greater proportion of high molecular weight RNAs. We 
concluded from that the profile from WT+E1 is not representative of this strain and suspected that 
something aberrant occurred during the rRNA  depletion step.
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Figure 36: Bioanalyzer results for WT+E, WT+J and JKO+J samples used for library construction.
The fragment size of the library WT+E1 replicate was high, so we decided not to sequence it 
since it would not be multiplexed properly with the other libraries. In order to maintain 2 replicates 
per  sample,  we used  RNA from the  the  original  WT+E1 in  order  to  construct  another  library 
(WT+E1B). This time, the rRNA depletion was performed using a different rRNA depletion kit and 
when compared with WT+E2 the sequence coverage from the two libraries revealed differences in 
some genes. This observation, combined with the observation of near complete rRNA depletion, led 
us to the hypothesis that some mRNAs could be depleted along with the rRNA and that using more 
input material might alleviate this.
Coming back to the profiles from figure 36, it is possible to conclude that the rRNA 
depletion reaction depleted similar material from samples WT+E2, WT+J1,  WT+J2 JKO+J1 and 
JKO+J2, but not for WT+E1. For this reason sample WT+E1 was excluded from the next analysis.
When analyzing the log2 ratios of the WT+J and WT+E and applying the cutoff of 2 fold 
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difference and an adjusted p-value smaller than 0.05 is was possible to obtain 25 upregulated genes 
and 1 downregulated gene. The low number of differentially expressed gene may be explained by 
the lack of statistical power due to the fact only one replicate of WT+E strain is being used.
Libraries for the JKO+J were also constructed, and since the complementation vector is 
using a stronger promoter than RNase J native promoter, this strain can also be considered an 
overexpression strain although it has less RNase J expression then the WT+J strain. The JKO+J 
strain, after applied the cutoff mentioned earlier, had 45 upregulated genes and 4 downregulated 
genes. The following figure show the comparison between the differentially expressed genes from 
WT+J and JKO+J when compared to WT+E:
Figure 37: Overall analysis of number of genes up and downregulated for the RNase J overexpression 
and complemented strains, and the overlap between the 2 sets of genes.
The figure shows an overlap of 11 genes for the upregulated lists, but no overlap when 
looking at the downregulated genes. By looking a little closer to the upregulated gene list for the 
JKO+J/WT+E condition, we  noted  see the upregulation of the genes MSMEG_3928, 
MSMEG_3929 and MSMEG_3930 (Figure 38); which encodes for [NiFe] hydrogenase subunits 
alpha, delta and beta, respectively.
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Figure 38: Location of the operon which contains genes MSMEG_3928, MSMEG_3929 and 
MSMEG_3930. Screen shot of the view from Artemis (Rutherford et al, 2000).
The previous picture shows the location of the operon where the genes of interest are 
encountered in the minus strand of M. smegmatis genome. It is worth noting that the gene 
MSMEG_3927 which encodes the protein peptidase M52, a hydrogen uptake protein, and gene 
MSMEG_3932 which encodes the heat shock protein hspX, are also upregulated in the JKO+J 
strain.
Previous studies have shown that genes MSMEG_3931-MSMEG_3928 encode a enzyme 
known as Hyd3 which is regulated by the DosR regulon (Berney et al, 2014).  DosR is shown to act 
together with DosS and DosT, and regulates response under hypoxic conditions by maintaining the 
redox balance inside the cells (Berney et al, 2014). This balance is then maintained by activation of 
hydrogen production by 3 different hydrogenases: Hyd1, Hyd2 and Hyd3 (Berney et al, 2014). The 
log2 values obtained for those genes are around 6.34. This suggests that the JKO+J strain can not 
maintain the redox balance in the cells which may explain the absence of growth under oxidative 
stress conditions.
Table 23: Differentially expressed genes according with the 2 fold and p-value 0.05 cutoff for strains 
WT+J and JKO+J when compared with the WT+E. Values in italic are not significant.
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Orthologs in TB Synonym Product log2 ratio WJ/WE log2 ratio JJ/WE Function
MSMEG_0462 MmpS4 protein -0,77 -3,09 Membrane protein
MSMEG_3937 membrane protein 2,81 5,56 Membrane protein
MSMEG_3946 transmembrane protein 0,77 2,86 Membrane protein
MSMEG_5602 Possible exportin-1 protein 4,00 3,70 Membrane protein
Rv0242c MSMEG_0372 3-ketoacyl-ACP reductase FabG 0,31 2,69 Metabolism
MSMEG_2262 hydrogenase-2, small subunit HybA 1,17 1,74 Metabolism
MSMEG_2604 4-carboxymuconolactone decarboxylase PacC -3,81 -3,81 Metabolism
Rv1594 MSMEG_3199 quinolinate synthetase NadA 0,61 2,53 Metabolism
Rv1622c MSMEG_3232 cytochrome D ubiquinol oxidase subunit II Cyd B 1,20 2,84 Metabolism
MSMEG_3465 fatty-acid—CoA ligase 1,19 2,58 Metabolism
MSMEG_3927 peptidase M52, hydrogen uptake protein 1,00 5,86 Metabolism
MSMEG_3928 [NiFe] hydrogenase subunit alpha 2,32 6,02 Metabolism
MSMEG_3929 [NiFe] hydrogenase subunit delta 2,00 6,61 Metabolism
Table 23: continued
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Orthologs in TB Synonym Product log2 ratio WJ/WE log2 ratio JJ/WE Function
MSMEG_3931 [NiFe] hydrogenase subunit beta 2,17 6,34 Metabolism
MSMEG_3933 diacylglycerol O-acyltransferase 0,89 2,70 Metabolism
MSMEG_3935 integrase 0,83 2,16 Metabolism
Rv2004c MSMEG_3942 Possible adenylate kinase 0,64 2,67 Metabolism
Rv3130c MSMEG_3948 acyltransferase 1,58 4,55 Metabolism
Rv2032 / Rv312 MSMEG_3952 NAD(P)H nitroreductase 0,79 2,33 Metabolism
Rv3131 MSMEG_3955 NAD(P)H nitroreductase 0,38 4,79 Metabolism
Rv2379c MSMEG_4510 peptide synthetase mbtf 0,32 3,95 Metabolism
Rv2380c MSMEG_4511 linear gramicidin synthetase subunit B 0,42 3,17 Metabolism
MSMEG_4512 polyketide synthase 0,00 4,07 Metabolism
Rv2383c MSMEG_4515 non-ribosomal peptide synthetase 0,54 3,72 Metabolism
Rv3130c MSMEG_5242 acyltransferase -0,13 3,15 Metabolism
Rv2032 MSMEG_5246 NAD(P)H nitroreductase 0,33 3,02 Metabolism
Rv0983 MSMEG_5486 peptidase S1 and S6, chymotrypsin/Hap -0,84 2,63 Metabolism
MSMEG_5506  Possible oxidoreductase 3,70 3,46 Metabolism
Rv3588c MSMEG_6082 carbonic anhydrase -0,97 2,52 Metabolism
MSMEG_6511 acyl-CoA dehydrogenase 1,03 0,93 Metabolism
MSMEG_6512 acyl-CoA dehydrogenase 1,08 1,64 Metabolism
MSMEG_3926 cation-transporting ATPase Pma1 0,65 3,28 Metal binding
MSMEG_6422 ferritin family protein 1,03 1,32 Metal binding
Rv2470 MSMEG_4695 globin 0,82 2,08 Oxygen binding
MSMEG_3755 5S ribosomal RNA rrfA 4,68 5,50 Protein regulation
MSMEG_3756 23S ribosomal RNA rrlA 2,91 3,00 Protein regulation
MSMEG_4929 5S ribosomal RNA rrfB 4,43 3,97 Protein regulation
MSMEG_4930 23S ribosomal RNA rrlB 2,91 3,00 Protein regulation
Rv2752c MSMEG_2685 metallo-beta-lactamase superfamily protein (Rnase J) 2,32 2,85 Ribonuclease
Rv2031c MSMEG_3932 Predicted to be in the DosR|Rv3133c regulon 3,08 5,22 Stress response
Rv2026c MSMEG_3940 universal stress protein family protein 1,14 4,35 Stress response
Rv1996 / Rv2005c / Rv2623 MSMEG_3945 universal stress protein family protein 3,17 7,41 Stress response
Rv2026c MSMEG_3950 universal stress protein family protein 0,10 2,80 Stress response
Rv2027c / Rv3132c MSMEG_5241 GAF family protein 0,78 3,73 Stress response
MSMEG_5245 universal stress protein family protein 0,47 3,24 Stress response
MSMEG_5733 universal stress protein family protein -0,09 2,95 Stress response
MSMEG_2682 transcriptional regulator 0,00 4,09 Transcriptional regulator
MSMEG_4825 TetR family transcriptional regulator -1,46 -3,46 Transcriptional regulator
Rv3133c MSMEG_5244 DevR family transcriptional regulator 1,31 2,84 Transcriptional regulator
MSMEG_1786 STAS domain-containing protein 0,35 1,54 Transporter
MSMEG_2834 Cys tRNA 1,38 0,46 tRNA
MSMEG_5757 Glu tRNA 2,47 2,28 tRNA
MSMEG_6326 Ser tRNA 1,66 1,11 tRNA
MSMEG_6350 Ser tRNA 2,20 1,13 tRNA
MSMEG_0009 hypothetical protein 1,33 1,27 unknown
MSMEG_0987 hypothetical protein -0,30 2,92 unknown
MSMEG_1212 hypothetical protein -1,00 -3,32 unknown
MSMEG_1421 hypothetical protein 1,14 1,42 unknown
MSMEG_2826 hypothetical protein 1,29 1,33 unknown
MSMEG_3439 hypothetical protein 0,97 1,45 unknown
MSMEG_5154 hypothetical protein 1,39 1,97 unknown
MSMEG_5406 hypothetical protein 1,06 1,45 unknown
MSMEG_5461 hypothetical protein -1,35 -4,81 unknown
MSMEG_6209 hypothetical protein 1,47 1,89 unknown
6. DISCUSSION
6.1. OXIDATIVE STRESS PROFILES
Mtb will produce oxidative stress as it grows aerobically (Broden et al, 2016), so it evolved 
to have a array of protective enzymes against this stressor (Dussurget and Smith, 1998). Oxidative 
stress has also been reported to be one of the types of stress Mtb will face when infecting a host 
(Dussurget et al, 1998). With the objective of understand the mechanisms by which mycobacteria 
can avoid the host immune "attacks", RNA-seq libraries ans 5' end mapping libraries were 
constructed with M.smegmatis cells cultured with and without hydrogen peroxide. With this 
libraries was possible to look into how mRNA profile changes can help the mycobacterial cell to 
improve their response against oxidative stress conditions.
First, the ideal concentration for the assays has found to be 3.2 mM H2O2. For this particular 
concentration, cell growth was impaired but not completely stopped. This way we believe we were 
able to get the strongest level of response by the cells. Cells were chosen to be harvested at three 
and six hours time points because M.smegmatis generation time is around 3 hours.
When both test conditions (3h 3.2 mM H2O2 and 6h 3.2 mM H2O2) where compared with no 
H2O2 a cutoff of 2 fold and p-value of 0.05 was applied to get the list of the differentially expressed 
genes under these test conditions. The first thing we can notice is that that is a great overlap among 
the upregulated samples (76 genes) which is not seen in the downregulated genes where only 9 
genes were present in both samples. For the 3 hour time point, the majority of the differentially 
expressed genes were upregulated while for the 6 hour time point the majority of the differentially 
expressed genes were downregulated. This may be due to the fact that oxidative stress will induces 
reduction in protein production (Li et al, 2015) to save energy for the cell. Some tRNAs were found 
on the downregulated genes for the 6 hour time point which corroborate the idea that translation if 
reduced. An analysis using the software DAVID was performed using these 2 genes lists and it did 
not shown any statistically significant results for the downregulated genes. The upregulated genes 
87
on the other hand had enrichment of clusters, for both 3 hour and 6 hour time points, containing 
HNH nuclease genes, which was expected since they are know to be involved in DNA repair and 
were also previously shown to be upregulated in M. smegmatis under oxidative stress conditions 
(Pediaditakis et al, 2012 and Li et al, 2015). Another interesting set of genes found upregulated in 
our samples were MSMEG_6645, MSMEG_6646 and MSMEG_6647, which are involved in the 
methylcitrate  cycle.  This  pathway  was  also  reported  to  be  upregulated  in  TB  in  response  to 
oxidative stress (Voskuil et al., 2011). We can speculate about what is happening in the cell under 
oxidative stress conditions and why it upregulates this pathway. One possibility would be that, after 
some period of exposure to excess hydrogen peroxide, cells start to see lipid damage and in order to 
restore  balance  will  "discard"  the  damage  structures  and  create  new  ones  (Shell,  personal 
communication). Once the old lipids, which were damaged, are no longer useful, the cell might use 
the  β-oxidation pathway and the methylcitrate cycle to "recycle" its components (Shell, personal 
communication). 
Our  data  was also  compared to  Li  et  al,  2015 which  tested  exposure  of  culture  of  M. 
smegmatis in  early  log  phase  to  30  minutes  of  0.2  mM  H2O2 and  7  mM  H2O2.  A visual 
representation of this comparison can be seen on figure 17. Some clusters of genes showed similar 
trends for the 2 data sets,  like for example the upregulation of DNA repair  genes as discussed 
previously  on  section  4.2.  For  some  others  clusters  on  the  other  hand,  like  sigma  factors, 
transcription regulation and protective enzymes, there was not a clear trend that could be visualized 
in this data. It is interesting to notice that KatG was not found upregulated in any of the conditions  
tested in this study, which might indicate that the response seen to 3.2 mM H2O2 after 3 and 6 hours 
are capturing the profile of RNA expression of "late" responses to H2O2.   Also is important to 
noticed  that  the  libraries  constructed  in  this  study where  using  cells  in  late  log  phase  and  as 
previously reported,  the  phase  which  a  culture  is  can  influence  in  its  RNA expression  profile 
(Shemesh et al., 2006).
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When looking at the 5' end mapping libraries we can see that due to technical problems 
during  the  library  preparation,  the  reproducibility  of  the  biological  replicates  was  lower  than 
expected (figure 23). This impaired our ability to distinguish between transcription start sites and 
cleavage sites and for this reason a relatively high cutoff for the coverage of the converted libraries 
was  used,  in  order  to  compensate  for  those  technical  issues.  In order to differentiate the 
transcription start sites from the cleavage sites, the log2 ratio between the converted and non-
converted libraries from the same condition is taken. If a 5' end is a transcription start site, we 
expect it will have a log2 ratio greater than 0. The higher the ratio, the more likely that this specific 
5' end is a transcription start site. On the other hand, if the log2 ratio between the converted and non-
converted libraries is around 0, then this 5' end is likely to be a cleavage site.
We then took the 500 highest ratios for each condition tested, which should be representative 
of transcription start sites, and found their sequence logo. Similarly, the 500 lowest ratios for each 
condition, which should represent the cleavage sites, were run through a sequence logo software. As 
expected, the higher ratios did show and A and T rich region around -10 site and a purine (A or G) 
for the +1 nt position, which are characteristic of E. coli transcript start sites (Lodish et al, 2000) 
and for the lowest ratios a C was the most common nt found in position +1 which resembles Mtb 
cleavage sites (Shell et al, unpublished data).
Z-scores were then calculated to find the outliers in figures 26B to 26D in order to address 
which 5' ends were differently expressed in which comparison between 2 conditions. The cutoff of 
z-score of 3 was used in order to get the most significant outliers. Among the 3 conditions analyzed 
(noH2O2 vs H2O2 3h, noH2O2 vs H2O2 6h and H2O2 3h vs H2O2 6h) 80 differentially expressed 5' 
ends were found (table 25).
Future work for this project consists in analyze the remaining genes in the differentially 
expressed list and look into more detail to the differentially expressed 5' ends in order to find 
specific transcripts that get cleaved under oxidative stress conditions. All this knowledge will help 
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understand how mycobacteria is able to tolerate and avoid the effect of high ROS in its 
environment. The genes that have enhanced expression or transcript stability when under oxidative 
stress can be used as target for new drugs, for example, once blocking normal oxidative stress 
response may be critical in killing bacteria and avoid bacterial dormancy when infecting a host.
6.2. RNASE J KNOCKOUT AND OVEREXPRESSION PHENOTYPES
In order to understand the roles of RNase J and how this enzyme can change RNA profiles 
under stress response conditions, a strain with deletion of RNase J was created. Since mycobacteria 
is known by its low homologous recombination rates (Van Kessel and Hatfull, 2008) a strategy 
know as recombineering was used where a plasmid in transformed into WT strain to facilitate the 
exchange of genetic material with linear DNA fragments (Van Kessel and Hatfull, 2008). The 
recombineering strategy helped indeed with the success hate of the transformation and the KO 
strain could be constructed. As control proposes, the complementation of the deletion strain was 
performed by adding RNase J coding sequence back to the bacterial genome in order to restore this 
gene activity.
Besides testing the effects of the lack of RNase J in the cell, we decided to construct an 
overexpression RNase J strain to address any possible vantage or advantage excess of this enzyme 
could bring to those cells and have a more complete idea of the possible mechanism by which 
RNase J work in the cell.
Initially, those set of four strains (WT with empty vector control, overexpression, deletion 
strain with empty vector control and complemented KO) had their RNase J relative expression 
determinated (figure 27) and results came as expected, with the overexpression strain having the 
highest relative expression, followed by the complemented strain, WT and RNase J deletion, which 
relative expression was undetectable. The complementation strain, as discussed in section 5.1., had 
more expression than WT because the promoter used for the vector construction was a synthetic 
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promoter which showed to be stronger than the native promoter. For these particular set of 4 isolates 
growth rates, antibiotic tolerance, colony morphology assays were conducted (data not shown). The 
strongest phenotypes seeing were a higher tolerance to INH on killing assays for the deletion strain, 
as can be seen for strain JKO1+E1 on figure 31, which was not complemented and a defect in 
colony morphology for the JKO1+E1 which was restored in the complemented strain (data not 
shown). Data from our collaborators from Fortune's lab using clinical Mtb isolates also indicates 
that deletion of RNase J confers cells a higher tolerance to INH and Figaro et al, 2013 showed 
previously that deletion of RNase J in will cause a cell morphology defect in B. subtilis.
With all these information in hand we then decided to test the reproducibility of the 
phenotypes we were seeing with those strains by using different isolates from the same strains as 
shown in sections 5.2. and 5.3. both MIC assays for INH and RIF and the killing assay for INH 
were showing variability in RNase J deletion strains phenotypes. Even with the variability reported 
for the isolates from the same strains, some trends about the antibiotic tolerance assays can be draw. 
The RNase J deletion strain appear to have a MIC smaller than WT for both tested drugs (INH and 
RIF) and the overexpression strain seems to have equal or higher MIC values than WT. For the 
complemented strain observed values is more difficult to suggest an overall trend since they don't 
correlate with the relative RNase J expression levels once for INH the MIC were higher than WT 
and overexpression strains and for RIF the MIC value were between the WT and RNase J deletion 
values (table 15). Since the MIC assay is based in a reduction reaction, it was hypothesized that, due 
the fact the JKO+J showed higher upregulated values for hydrogenases subunits, the high values 
seen for strain JKO+J on the INH MIC assay would be not real. On the other hand this is not true 
when we look into the RIF MIC assay results, which suggests a similar trend as observed in the 
qPCR reaction for the relative expression level. For the INH killing assays performed for this 
project is also possible to see some variability among the isolates. While JKO1, JKO4, JKO6 and 
JKO9 isolates seems to have more resistance to INH challenge, the majority of the isolates (8 out of 
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12) suggest that RNase J there is little to no effect in improving mycobacteria survival of INH. We 
plan to perform a whole genome sequencing and southern blots assays in order to identify the 
possible mutations that these isolates might have that make then a little more tolerant to INH than 
WT strain, specially on isolate JKO1+E1, which were showing an extreme phenotype in the killing 
assays performed during this project.
Next, we decided to challenge the RNase J deletion strain with hydrogen peroxide. 
Oxidative stress has being shown to contribute with INH toxicity (Dussurget and Smith, 1998) so 
we wanted to investigate if the selection for RNase J deletion strains saw by our collaborators could 
be actually due to the tolerance to oxidative stress and not so much by the drug itself. To address 
that cells were cultured with 3.2 mM H2O2 for about 30 hours and growth was measured by taking 
OD600's periodically. Surprisingly, our preliminary data shows that RNase J is capable of growing 
under oxidative stress conditions, although not in the same rate as WT (Figure 35). The 
overexpression and the complemented strains did not shown any growth on the conditions tested. 
These results suggests that excess of RNase J is detrimental to the cell when challenged with H2O2. 
It  is important to notice that after 30h of incubation,  the levels of H2O2 in the samples are not 
significant anymore which can lead us to conclude that the cells of the strains WT+J and JKO+J are 
likely non-viable anymore. It would be also interesting to look at other ROS generator, which might 
be more stable than hydrogen peroxide but also induce a different from what we have seen from this 
work.
Finally, the expression libraries constructed for the complemented strain showed one operon 
where almost all genes were upregulated. MSMEG_3928, MSMEG_3929 and MSMEG_3930 
(figure 35) encodes for [NiFe] hydrogenase subunits alpha, delta and beta respectively are part of 
these operon and together form the protein Hyd3, which is regulated by the DosR stress response 
regulon (Berney et al, 2014). Although this result suggests that more expression of RNase J triggers 
stress reponse, those genes are not found to be upregulated in the overexpression strain. The only 
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gene that belong to this specif operon that is upregulated in both complemented and overexpression 
strains is MSMEG_3932, which encodes the heat shock protein hspX. More investigation at the 
differentially expressed genes needs to be done in order to completely understand RNase J function 
in mycobacteria.
As future directions for this project, we can cite the need to find the real phenotype for the 
RNase J deletion strain in order to understand the roles this enzyme may have in mRNA profiles 
changes in mycobacteria and possible oxidative stress tolerance. It would also be interesting to 
perform whole genome sequencing on the JKO1+E1 strain to verify what kind of additional 
mutation happened during the transformation procedure and how this had such a great influence in 
the strains phenotype. The data collected from the expression library for this strain can also help to 
find this possible mutation by looking at the possible SNPs in its genome when compared to WT 
genome.
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7. APPENDIX
7.1. PRIMERS SEQUENCES:
Table 24: Sequences of the primes used during this project in alphabetical order. N means any of the 4 
nucleotides chosen randomly and the red sequences shows the unique sequences of each index used for library 
construction.
Primer Name Sequence 5' to 3'
Bioo kit Index 1 CAAGCAGAAGACGGCATACGAGATGTGTTCTAGTGACTGGAGTTCAG
ACGTG
Bioo kit Index 2 CAAGCAGAAGACGGCATACGAGATAAACATCGGTGACTGGAGTTCAG
ACGTG
Bioo kit Index 4 CAAGCAGAAGACGGCATACGAGATGTCTGTCAGTGACTGGAGTTCAG
ACGTG
Epicentre Kit 
Index 7
CAAGCAGAAGACGGCATACGAGATGTCTAGGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
Epicentre Kit 
Index 8
CAAGCAGAAGACGGCATACGAGATTGAACTGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
Epicentre Kit 
Index 9
CAAGCAGAAGACGGCATACGAGATCTAGTCGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
Epicentre Kit 
Index 10
CAAGCAGAAGACGGCATACGAGATATCGAAGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
Epicentre Kit 
Index 11
CAAGCAGAAGACGGCATACGAGATCCGATGGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
Epicentre Kit 
Index 12
CAAGCAGAAGACGGCATACGAGATGAACATGTGACTGGAGTTCAGAC
GTGTGCTCTTCCGATCT 
JR 273 GACTACACCAAGGGCTACAAG
JR 274 TTGATCACCTCGACCATGTG
SSS 392 TCCCTACACGACGCTCTTCCGAUCU
SSS 397 CTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNN*
SSS 398 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTC
TTC
SSS 399 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGAC
GTGTGCT
SSS 401 AATGATACGGCGACCACCGAGATC
SSS 402 CAAGCAGAAGACGGCATACGAGAT
SSS 403 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCAGAC
GTGTGCT
SSS 583 ACTAGCGTACGATCGACTGC
SSS 584 ACCAGCCCGTCATCGTCAAC
SSS 589 ATCTGCCGGTCGTGCTGTAC
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SSS 590 GTTGACGATGACGGGCTGGTGAATCCCCTACCTGAGGACC
SSS 591 GCAGTCGATCGTACGCTAGTGCGATCTGAGCTCAACCCG
SSS 592 TCGACATGGGCAACGCGCT
SSS 593 GGTCTGCTCGCACACTTCAC
SSS 594 GCACAGCATCCGGGTGAAC
SSS 644 GTGAGCGCTCACAATTCGGATCCAGGAAGGAGATATACATATGAGCGC
CGAACTCGC
SSS 645 TCAGTTAACTACGTCGACATCGATATCAGATCTCTATGACGGTCG
SSS 651 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGAC
GTGTGCT
SSS 653 CAAGCAGAAGACGGCATACGAGATGGACGGGTGACTGGAGTTCAGAC
GTGTGCT
SSS 654 CAAGCAGAAGACGGCATACGAGATCTCTACGTGACTGGAGTTCAGAC
GTGTGCT
SSS 655 CAAGCAGAAGACGGCATACGAGATGCGGACGTGACTGGAGTTCAGAC
GTGTGCT
SSS 656 CAAGCAGAAGACGGCATACGAGATTTTCACGTGACTGGAGTTCAGAC
GTGTGCT
SSS 657 CAAGCAGAAGACGGCATACGAGATGGCCACGTGACTGGAGTTCAGAC
GTGTGCT
SSS 658 CAAGCAGAAGACGGCATACGAGATCGAAACGTGACTGGAGTTCAGAC
GTGTGCT
SSS 659 CAAGCAGAAGACGGCATACGAGATCGTACGGTGACTGGAGTTCAGAC
GTGTGCT
SSS 660 CAAGCAGAAGACGGCATACGAGATCCACTCGTGACTGGAGTTCAGAC
GTGTGCT
SSS 661 CAAGCAGAAGACGGCATACGAGATGCTACCGTGACTGGAGTTCAGAC
GTGTGCT
SSS 706 TCATCCTCTCATCGGGTTTC
SSS 707 TTCGCGCTCAACCTTCT
SSS 708 ACGGGCGACATCAAACT
SSS 709 TGGAATCGCACAGGAACA
SSS 710 GTGACGGTCGGCAAGAT
SSS 711 AAACCCGATGAGAGGATGAG
SSS 786 CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTCAGAC
GTG
SSS 787 CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGTTCAGAC
GTG
SSS 789 CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTCAGAC
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GTG
7.2. PRIMERS EFFICIENCY FOR qPCR
Figure 39: Primers tested prior to run the relative expression qPCR for RNase J. Primer set SSS706-707 
was the one chosen for the following experiments and primer set JR273-274 are the validation primers that 
amplify a region of the housekeeping gene sigA.
7.3. Z-SCORES VALUES
Table 25: Z-scores for the 5'end mapping libraries. The green values show the significant values with the 
cutoff of a Z-score of more than 3. The unique identifier correspond to the nucleotide position at the genome with 
the strand were the gene is located (plus or minus strand).
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7.4. MEDIA RECIPES
7.4.1. M. smegmatis MEDIA recipes
Recipe for 1 L of Middlebrook 10x ADC supplement:
• 1 L Milli Q water
• 50 g BSA fraction V
• 20 g Dextrose
• 8.5 g NaCl
• 30 mg Catalase
Media was filter sterilized and stored at 4 °C until use.
Recipe for 1 L of Middlebrook 10x ADS supplement (for oxidative stress experiments):
• 1 L Milli Q water
• 50 g BSA fraction V
• 20 g Dextrose
• 8.5 g NaCl
Media was filter sterilized and stored at 4 °C until use.
Recipe for 1 L of Middlebrook 7H9 Broth
• 900 mL Milli Q water
• 4.7 g 7H9 Broth powder
• 2.5 mL 20% Tween 80
• 4 mL 50% glycerol
• 100 mL 10x ADC or ADS
Media was filter sterilized and stored at 4 °C until use.
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Recipe for 1 L of Middlebrook 7H10 Agar
• 900 mL Milli Q water
• 19 g 7H10 Agar powder
• 10 mL 50% glycerol
Media was autoclaved 20 minutes at 121 °C and when medium cooled down 100 mL ADC 
was added and antibiotic if needed. 25 mL of media was then poured in each petri dish and when 
solid stored at 4 °C until use. In the case of square plate 35 mL per plate is used.
7.4.2. E. coli MEDIA recipes
Recipe for 1 L of LB Broth
• 1 L Milli Q water
• 25 g LB Broth powder
 Media was autoclaved 20 minutes at 121 °C and stored in room temperature until use.
Recipe for 1 L of LB Agar
• 1 L Milli Q water
• 40 g LB Agar powder
Media was autoclaved 20 minutes at 121 °C and stored in room temperature until use.
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